US Pat. No. 10,765,719

CEACAM BASED ANTIBACTERIAL AGENTS

1. A multimer therapeutic agent consisting of two different isolated peptides selected from the group consisting of SEQ ID No. 21 SEQ ID No. 24.
US Pat. No. 10,766,231

PRINTABLE PROTECTIVE LAYER

PERFORMANCE MATERIALS NA,...

1. A coextruded multilayer film comprising a first surface layer and a second surface layer wherein:the first surface layer consisting of a cross-linked, non-weldable, partially neutralized copolymer of ethylene and one or more ?,?-unsaturated C3 to C8 carboxylic acid and optionally, from 0.001 to 10 wt. % of a plasticizer, processing aid, flow enhancing additive, lubricant, pigment, dye, flame retardant, impact modifier, nucleating agent, antiblocking agent, thermal stabilizer, UV absorber, UB stabilizer, dispersant, surfactant, chelating agent, coupling agent, adhesive, primer, antistatic agent, crosslinking agent, or slip agent; and
the second surface layer comprises an internal layer comprising a polyamide and an external layer, the external layer consisting of:
(i) a grafted propylene or a grafted copolymer of propylene and one or more ?-olefin; and
(ii) optionally, from 0.001 to 10 wt. % of a plasticizer, processing aid, flow enhancing additive, lubricant, pigment, dye, flame retardant, impact modifier, nucleating agent, antiblocking agent, thermal stabilizer, UV absorber, UV stabilizer, dispersant, surfactant, chelating agent, coupling agent, adhesive, primer, antistatic agent, crosslinking agent, or slip agent.
US Pat. No. 10,766,999

POLY(AMIDE-IMIDE) RESIN COMPOSITION AND FLUOROCHEMICAL COATING MATERIAL

HITACHI CHEMICAL COMPANY,...

1. A fluorochemical coating material comprising a fluororesin and a polyamideimide resin composition comprising: (A) a polyamideimide resin which has isocyanate groups at terminals and in which at least a portion of the isocyanate groups are blocked with a blocking agent selected from the group consisting of alcohols, oximes and lactams, (B) N-formylmorpholine, and (C) water.
US Pat. No. 10,765,720

COMPOSITION FOR PREVENTING OR TREATING HYPEROXIA-INDUCED LUNG INJURY COMPRISING WKYMVM PEPTIDE AS AN ACTIVE INGREDIENT

SAMSUNG LIFE PUBLIC WELFA...

1. A method of treating hyperoxia-induced lung injury comprising:administering to a subject in need thereof an effective amount of a WKYMVm peptide, the WKYMVm peptide comprising the sequence of SEQ ID NO: 1,
wherein the hypoxia-induced lung injury is bronchopulmonary dysplasia, and
wherein the effective amount of the WKYMVm is from 1-100 ?M.
US Pat. No. 10,765,721

MANUFACTURE OF DEGARELIX

Ferring B.V, Hoofddorp (...

1. A lyophilized degarelix drug substance having a viscosity of up to 3.2 mPas, as determined upon dissolution in an amount of 20 mg degarelix free base in 1 ml of water containing 2.5% (w/V) mannitol, and the lyophilized degarelix drug substance has an acetic acid concentration ranging from 4.5% to 10.00% (w/w) and a water content of 10% (w/w) or less, wherein the lyophilized degarelix drug substance is prepared by a method, comprising:a. purifying degarelix obtained by a liquid or solid phase peptide synthesis to obtain a degarelix solution with a purity of at least 95%, as determined by high-performance liquid chromatography (HPLC);
b. evaporating a solvent to concentrate the degarelix solution to obtain aggregated degarelix;
c. deaggregating the aggregated degarelix with acetic acid to obtain deaggregated degarelix; and
d. lyophilizing the deaggregated degarelix to provide the lyophilized degarelix drug substance.
US Pat. No. 10,767,001

EPOXY RESIN CURING AGENT, EPOXY RESIN COMPOSITION, AND CARBON FIBER-REINFORCED COMPOSITE MATERIAL

MITSUBISHI GAS CHEMICAL C...

1. An epoxy resin curing agent comprising an amine compound (A) represented by the following formula (1) and a phenol compound (B), wherein the content of the component (B) is from 8 to 35 parts by mass relative to 100 parts by mass of the component (A):R1HN—H2C-A-CH2—NHR2  (1)
wherein R1 and R2 each independently represents a hydrogen atom or an aminoalkyl group having 1 to 6 carbon atoms, and A represents a cyclohexylene group or a phenylene group,
wherein the total content of the amine compound (A) and the phenol compound (B) is from 80% by mass to 100% by mass, relative to the total amount of the epoxy resin curing agent.
US Pat. No. 10,765,722

ANGIOTENSIN II ALONE OR IN COMBINATION FOR THE TREATMENT OF HYPOTENSION

The George Washington Uni...

1. A method of treating a hypotensive human patient suffering from acute kidney injury, comprising administering angiotensin II to the patient at an initial rate of about 0.25 to 10 ng/kg/min and titrating the rate down to achieve and/or maintain a target mean arterial pressure (MAP) of at least about 65 mmHg in the patient.
US Pat. No. 10,765,723

USE OF LOW DOSE IL-2 FOR TREATING AUTOIMMUNE—RELATED OR INFLAMMATORY DISORDERS

SORBONNE UNIVERSITE, Par...

1. A method for treating systemic vasculitis, the method comprises administering to a human subject in need thereof an effective amount of repeated doses of interleukin-2 (IL-2), wherein each dose of the IL-2 is between 0.1 MIU/day and 3.5 MIU/day.
US Pat. No. 10,766,235

REINFORCED FILM FOR UNITIZATION OF GOODS

Megaplast S.A. Packaging ...

1. A non-perforated reinforced stretch film consisting of:a base film which has a thickness in the range of 3 ?m to 18 ?m, and 5 to 100 reinforcing strips fixed on at least one surface of said base film, wherein the width of each reinforcing strip is, independently, in the range of 1 mm to 17 mm.
US Pat. No. 10,765,724

METHOD OF TREATING PSORIASIS WITH INCREASED INTERVAL DOSING OF ANTI-IL12/23 ANTIBODY

Janssen Biotech, Inc., H...

1. A method of treating psoriasis in a a patient using an increasing dosing or maintenance interval, comprising administering a pharmaceutical composition comprising an antibody to both IL-12 and IL-23 to the patient, wherein the antibody comprises a heavy chain variable amino acid sequence of SEQ ID NO: 7 and a light chain variable amino acid sequence of SEQ ID NO: 8, in an initial dose, a dose 4 weeks after the initial dose and a dose once every 12 weeks for 24 weeks after administration of the initial dose and increasing the dosing interval 28 weeks after administration of the initial dose to a dosing interval of every 24 weeks after identifying the patient as a responder to the antibody 28 weeks after administration of the initial dose, wherein the dose is 45 mg or 90 mg.
US Pat. No. 10,767,004

TRICYCLODECANE DIMETHANOL COMPOSITION AND USES THEREOF

DAIREN CHEMICAL CORPORATI...

1. A composition comprising:a first component which is tricyclodecane dimethanol, and
a second component,
wherein when the composition is characterized in a gas chromatography, the tricyclodecane dimethanol is eluted at a retention time ranging from 12.4 minutes to 13 minutes, the second component is eluted at a retention time ranging from 11.8 minutes to 12.4 minutes, each indicated by elution peaks at respective retention times in a spectrum, and the ratio of the area of elution peaks indicating the second component compared to the area of elution peaks indicating the tricyclodecane dimethanol is between 0.001:1 and 0.04:1.
US Pat. No. 10,768,541

TONER FOR DEVELOPING ELECTROSTATIC IMAGES

KONICA MINOLTA, INC., To...

1. A toner for developing electrostatic images comprising at least a binder resin and a colorant containing a copper phthalocyanine compound, whereinin X-ray diffraction using a CuK? ray, the toner has peaks at a Bragg angle of 2?=7.0±0.1° and at a Bragg angle of 2?=9.1±0.2° and
additionally has a peak between the two peaks.
US Pat. No. 10,765,725

METHODS FOR TREATMENT OF SURGERY ASSOCIATED PAIN

1. A method of preventing or treating pain in a subject, comprising the step of administering growth hormone to said subject immediately prior, during, or after a surgical event, wherein said administration is to a site of a cutaneous and/or muscular inflammation associated with said surgical event.
US Pat. No. 10,767,005

BIBENZOATE COPOLYESTERS AND METHODS TO PRODUCE THEM

ExxonMobil Chemical Paten...

1. A copolyester comprising:a diol component comprising from about 10 to 90 mole percent ethylene glycol and from about 90 to 10 mole percent 1,4-cyclohexanedimethanol, based on the total moles of the diol component in the copolyester; and
a diacid component comprising 4,4?-biphenyl dicarboxylate and 3,4?-biphenyl dicarboxylate, wherein the diacid component comprises from about 50 to 90 mole percent of the 4,4?-biphenyl dicarboxylate and from about 50 to 10 mole percent of the 3,4? biphenyl dicarboxylate, based on the total moles of the diacid component in the copolyester;
wherein the copolyester has an essentially amorphous morphology and a glass transition temperature equal to or greater than about 110° C. determined by differential scanning calorimetry (DSC) analysis from a second heating ramp at a heating rate of 10° C./min; or
wherein the copolyester has a semicrystalline morphology, a melting temperature of equal to or less than 250° C. determined by DSC analysis from a second heating ramp at a heating rate of 10° C./min, and a glass transition temperature equal to or greater than 120° C. determined by DSC analysis from a second heating ramp at a heating rate of 10° C./min.
US Pat. No. 10,765,726

UNIT DOSE FORMULATION OF ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME

Portola Pharmaceuticals, ...

1. A method for reversing anticoagulation in a subject undergoing an anticoagulant therapy with a factor Xa inhibitor, comprising administering to the subject from about 10 mg to about 2 grams of a two-chain polypeptide comprising a first chain comprising the amino acid sequence of SEQ ID NO:14 or a first polypeptide having at least 90% sequence identity to SEQ ID NO:14, and a second chain comprising the amino acid sequence of SEQ ID NO:15 or a second polypeptide having at least 95% sequence identity to SEQ ID NO:15, wherein the two-chain polypeptide has reduced catalytic activity as compared to the wild-type factor Xa protein, and is capable to bind to the factor Xa inhibitor.
US Pat. No. 10,768,543

TONER

Canon Kabushiki Kaisha, ...

1. A toner havinga toner particle which contains a binder resin, and
inorganic fine particles, wherein
the binder resin contains a polyester resin,
the polyester resin has, at a terminal, an alkyl group having an average number of carbon atoms of from 4 to 102,
a number average particle diameter of primary particles of the inorganic fine particles is from 10 to 90 nm,
a dielectric constant of the inorganic fine particles is from 55.0 to 100.0 pF/m, as measured at 25° C. and 1 MHz, and
the inorganic fine particles are surface-treated with an alkylalkoxysilane represented by the following formula (1):
CnH2n+1—Si?OCmH2m+1)3  (1)
wherein, n denotes an integer of from 4 to 20, and m denotes an integer of from 1 to 3.
US Pat. No. 10,765,727

COMPOSITIONS AND METHODS FOR PRODUCING DENDRITIC CELLS

Primevax Immuno-Oncology,...

1. A method for treating or reducing melanoma, comprising:obtaining primed dendritic cells by a process comprising the steps of: contacting dendritic cells with a tumor antigen, lipopolysaccharide, R848, and interferon-gamma;
administering the primed dendritic cells to a subject in need thereof; and
administering a Dengue Virus to the subject, wherein the Dengue Virus is serotype 2 strain #1710, and wherein the subject has melanoma.
US Pat. No. 10,767,263

THIN METAL-ORGANIC FRAMEWORK FILM

IMEC VZW, Leuven (BE)

1. A substrate structure comprising:a substrate having a main surface;
a metal organic framework (MOF) film on said main surface, wherein said MOF film has a thickness range of 1 nm to 250 nm and is pin-hole free; and
a conformal layer of a dielectric material, wherein the conformal layer is positioned between the main surface of the substrate and the MOF film and wherein the conformal layer of dielectric material comprises an oxide layer.
US Pat. No. 10,765,728

METHOD FOR GENERATING IMMUNE CELLS RESISTANT TO ARGININE AND/OR TRYPTOPHAN DEPLETED MICROENVIRONMENT

CELLECTIS, Paris (FR)

1. A method of treating an arginase I producing cancer that inhibits T-cell activity, comprising administering to a patient in need thereof a therapeutically effective amount of an engineered human T-cell comprising at least one insertion, deletion, or addition to a GCN2 or PRDM1 gene conferring arginase resistance, wherein said cancer is selected from the group consisting of lung cancer, breast cancer, uterine cancer, prostate cancer, kidney cancer, colon cancer, liver cancer, pancreatic cancer, and skin cancer.
US Pat. No. 10,767,008

POLYMER POLYOLS COMPRISING AMINE BASED POLYETHER POLYOLS AND A PROCESS FOR PREPARING THESE POLYMER POLYOLS

Covestro LLC, Pittsburgh...

1. A polymer polyol having a solids content greater than about 15% by weight and less than 30% by weight, based on the total weight of the polymer polyol, and comprising the free-radical polymerization product of:(a) one or more base polyols comprising at least one of
(I) a blend comprising
(1) one or more amine initiated polyols wherein the amine initiator is free of tertiary amine groups and said amine initiated polyols have an equivalent weight of less than 500,
and
(2) one or more hydroxyl initiated polyols having a functionality of from about 2 to about 8 and a hydroxyl number of from about 10 to about 1000, wherein said hydroxyl initiated polyols are selected from the group consisting of polyether polyols, polyester polyols, polyetherester polyols and mixtures thereof;
or
(II) one or more amine initiated polyols wherein the amine initiator comprises an alkanolamine and is free of tertiary amine groups, and said amine initiated polyols have an equivalent weight of less than 500;
(b) at least one preformed stabilizer further comprising a polymer control agent;
and
(c) one or more ethylenically unsaturated monomers;
combined in the presence of
(d) at least one free radical polymerization catalyst;
and, in the absence of
(e) additional polymer control agent which is added separately from the preformed stabilizer.
US Pat. No. 10,765,729

TUMOR ANTIGEN PEPTIDE

Sapporo Medical Universit...

1. An antigen peptide represented by Y0-X0-Z0, whereinX0 is any of (1) to (2) below:
(1) SEQ ID NO: 3 in which the second amino acid from the N terminal is replaced by leucine, isoleucine or methionine, and/or the amino acid at the C terminal is replaced by leucine or isoleucine;
or
(2) SEQ ID NO: 3 in which the second amino acid from the N terminal is replaced by phenylalanine, methionine or tryptophan, and/or the amino acid at the C terminal is replaced by leucine, isoleucine or phenylalanine; and,
Y0 and Z0 are mutually independently a peptide consisting of 0 to 5 amino acids.
US Pat. No. 10,767,009

PROCESS FOR PREPARING POLYETHER POLYOL USING DMC CATALYST AND CONTINUOUS ADDITION OF STARTER

Covestro LLC, Pittsburgh...

1. A process for making a polyether polyol product, comprising:a) activating a DMC catalyst complex in the presence of i) an alkoxylated starter having a hydroxyl equivalent weight of 50 to 100% of the hydroxyl equivalent weight of the polyether polyol product and ii) up to 10 weight-%, based on the weight of the alkoxylated starter, of 1,2-propylene oxide;
b) continuously feeding an alkylene oxide containing at least 50 weight-% 1,2-propylene oxide to the activated DMC catalyst under polymerization conditions,
wherein starting at the beginning of step b), a low equivalent weight starter is fed continuously to the activated DMC catalyst under polymerization conditions, the feed of low molecular weight starter is continued until 80 to 95% of the alkylene oxide feed in step b) has been completed and the feed of low molecular weight starter is then discontinued while continuing the alkylene oxide feed, wherein the total weight of low molecular weight starter added in step b) is 0.2 to 25% of the total weight of alkylene oxide added in step b).
US Pat. No. 10,765,730

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS

IMMATICS BIOTECHNOLOGIES ...

1. A method of producing an antibody specifically binding to an MHC class I molecule complexed with an antigen consisting of the amino acid sequence of VQLDSIEDLEV (SEO ID NO: 32), comprisingimmunizing a genetically engineered non-human mammal comprising cells expressing said human major histocompatibility complex (MHC) class I molecule with a soluble form of an MHC class I molecule complexed with an antigen consisting of the amino acid sequence of VQLDSIEDLEV (SEO ID NO: 32);
isolating mRNA molecules from antibody producing cells of said non-human mammal;
producing a phage display library displaying protein molecules encoded by said mRNA molecules; and
isolating at least one phage from said phage display library, wherein said at least one phage displays said antibody specifically binding to said MHC class I molecule complexed with an antigen consisting of the amino acid sequence of VQLDSIEDLEV (SEO ID NO: 32).
US Pat. No. 10,767,010

PURIFIED POLY(PHENYLENE ETHER), AND POLY(PHENYLENE ETHER) COMPOSITION AND ARTICLE

SABIC GLOBAL TECHNOLOGIES...

1. A process for purification of a poly(phenylene ether), the process comprisingcontacting a liquid feed solution comprising
the poly(phenylene ether),
an organic acid impurity, and
an amine impuritywith a hydrated acidic clay adsorbent under contacting conditions effective to provide a liquid effluent solution, in whichthe weight average molecular weight of the poly(phenylene ether) is within 1 percent, of the weight average molecular weight of the poly(phenylene ether) in the feed solution, and
a concentration of the amine impurity and the organic acid impurity in parts per million by weight is each reduced by at least 40 percent relative to the concentration of each in the feed solution.
US Pat. No. 10,765,731

FUSION OF HETEROOLIGOMERIC MYCOBACTERIAL ANTIGENS

TRANSGENE SA, Illkirch G...

1. A viral vector comprising:a nucleic acid molecule encoding a fusion of the heterooligomeric mycobacterial antigens ESAT6 with CFP10, and
nucleic acid molecule(s) encoding one or more additional mycobacterial antigen(s) selected from the group consisting of Ag85B (Rv1886), RpfB, RpfD, Rv1813, Rv2626, Rv3407, and a mycobacterial antigen comprising an amino acid sequence as set forth in SEQ ID NO: 3 or 4.
US Pat. No. 10,767,011

TRANSPARENT POLYAMIDE MOULDING COMPOSITIONS WITH HIGH TENSILE STRAIN AT BREAK

1. A polyamide moulding composition consisting of the following constituents:(A) 50 to 100% by weight of at least one transparent polyamide composed of:
(a1) 60 to 77 mol % of a linear aliphatic diamine having 6 to 10 carbon atoms;
(a2) 23 to 33 mol % of exclusively bis(4-amino-3-methylcyclohexyl)methane (MACM),
where the proportions of (a1) and (a2) are based on an entirety of the diamines used and give a total of 100 mol %;
(a3) 40 to 80 mol % of a mixture of terephthalic acid and isophthalic acid in a molar ratio of 1.5:1-1:1.5; and
(a4) 20 to 60 mol % of an acyclic, linear aliphatic dicarboxylic acid selected from the group consisting of decanedioic acid, undecanedioic acid, dodecanedioic acid, and mixtures thereof;
where the proportions of (a3) and (a4) are based on an entirety of the dicarboxylic acids used and give a total of 100 mol %; and
(B) 0 to 50% by weight of additives;
wherein an entirety of components (A) and (B) gives 100% by weight.
US Pat. No. 10,765,732

COMPOUNDS AND METHODS FOR AFFECTING CYTOKINES

ZIVO BIOSCIENCE, INC., K...

1. A method of treating mastitis in a cow, said method comprising administering to said cow a therapeutically effective amount of one or more liquid fractions of a sterile bioactive liquid obtained by filtering an incubated culture of ATCC Deposit No. PTA-5863 through sterilizing membrane filters and subjecting the sterile filtrate to chromatographic fractionation, wherein said one or more liquid fractions up-regulate at least one anti-inflammatory cytokine in bovine mammary epithelial cells, and/or down-regulate at least one pro-inflammatory cytokine in bovine mammary epithelial cells.
US Pat. No. 10,767,012

FUNCTIONALIZED POLYAMIDES AND METHODS OF PREPARING THE SAME

1. A process of preparing a functionalized polyamide comprising reacting a thio acid with (i) an amide monomer or (ii) a mixture of a diamine and a dicarboxylic acid, wherein the thio acid has the general formula HOOC-A-SH wherein A represents an alkylene group containing from 2 to 10 carbon atoms, further wherein 0.01 to 2 weight percent of the thio acid, based upon the weight of the (i) the amide monomer or (ii) the mixture of the diamine and the dicarboxylic acid, is used to prepare the functionalized polyamide.
US Pat. No. 10,765,733

FILOVIRUS CONSENSUS ANTIGENS, NUCLEIC ACID CONSTRUCTS AND VACCINES MADE THEREFROM, AND METHODS OF USING SAME

The Trustees of the Unive...

1. A composition comprising: a first plasmid that comprises a nucleic acid sequence that encodes SEQ ID NO:1 or SEQ ID NO:1 linked to an IgE signal peptide; a second plasmid that comprises a nucleic acid sequence that encodes SEQ ID NO:2 or SEQ ID NO:2 linked to an IgE signal peptide; and a third plasmid that comprises a nucleic acid sequence that encodes SEQ ID NO:3 or SEQ ID NO:3 linked to an IgE signal peptide.
US Pat. No. 10,765,734

INFLUENZA PEPTIDES AND COMPOSITIONS

PepTcell Limited, London...

1. A polypeptide composition, the composition comprising an adjuvant and one or more isolated polypeptides, each of the one or more isolated polypeptides being from 8 to 50 amino acids in length,wherein the one or more isolated polypeptides include
a polypeptide comprising an amino acid sequence with 85% or more amino acid sequence identity to SEQ ID NO: 1 or a fragment of SEQ ID NO: 1 having 8 or more consecutive amino acids from SEQ ID NO: 1,
a polypeptide comprising an amino acid sequence with 85% or more amino acid sequence identity to SEQ ID NO: 2 or a fragment of SEQ ID NO: 2 having 8 or more consecutive amino acids from SEQ ID NO: 2,
a polypeptide comprising an amino acid sequence with 85% or more amino acid sequence identity to SEQ ID NO: 3 or a fragment of SEQ ID NO: 3 having 8 or more consecutive amino acids from SEQ ID NO: 3,
a polypeptide comprising an amino acid sequence with 85% or more amino acid sequence identity to SEQ ID NO: 4 or a fragment of SEQ ID NO: 4 having 8 or more consecutive amino acids from SEQ ID NO: 4,
a polypeptide comprising an amino acid sequence with 85% or more amino acid sequence identity to SEQ ID NO: 5 or a fragment of SEQ ID NO: 5 having 8 or more consecutive amino acids from SEQ ID NO: 5, and
a polypeptide comprising an amino acid sequence with 85% or more amino acid sequence identity to SEQ ID NO: 6 or a fragment of SEQ ID NO: 6 having 8 or more consecutive amino acids from SEQ ID NO: 6,
wherein, the one or more polypeptides are immunogenic to one or more influenza strains in a vertebrate expressing a major histocompatibility complex (MHC) allele, and wherein the one or more isolated polypeptides are not a complete influenza virus protein.
US Pat. No. 10,767,014

METHOD FOR MANUFACTURING TRANSPARENT POLYIMIDE FILM

TAIMIDE TECH. INC., Hsin...

1. A method for manufacturing a transparent polyimide film, comprising:providing a polyamic acid solution having a fluorine content more than 12%, and the polyamic acid solution including 4,4?-(4,4?-isopropylidenediphenoxy)bis-(phthalic anhydride);
adding a dehydrating agent and a catalyst into the polyamic acid solution, the dehydrating agent having an equivalent number equal to or larger than 3;
performing a chemical imidization process to form a polyimide solution; and
baking the polyimide solution under a temperature ranging from 250 to 260° C. so that the transparent polyimide film which has a b* value in a CIELAB coordinate of less than 1.3 is obtained.
US Pat. No. 10,767,015

OPTICAL MATERIAL COMPOSITION AND OPTICAL MATERIAL

MITSUBISHI GAS CHEMICAL C...

1. A composition for optical materials, consisting of:an episulfide compound (A) in an amount of 65 to 90 parts by mass with respect to 100 parts by mass of the composition,
a polythiol compound (B) in an amount of 10 to 35 parts by mass with respect to 100 parts by mass of the composition,
a photochromic compound (C) in an amount of 0.01 to 0.5 parts by mass with respect to 100 parts by mass of the composition, and
sulfur as an optional component, an optional polymerization catalyst and an optional curing catalyst;
wherein the photochromic compound (C) is selected from the group consisting of a spiropyran compound, a spirooxazine compound, a spiroperimidine compound, a benzopyran compound, a fulgide compound, a naphthopyran compound, a diarylethene compound, and an azobenzene compound.
US Pat. No. 10,765,737

METHODS FOR TREATING HEART FAILURE USING GLUCAGON RECEPTOR ANTAGONISTIC ANTIBODIES

REMD Biotherapeutics, Inc...

1. A method for treating heart failure in a subject in need thereof comprising administering to the subject a therapeutically effective amount of an isolated antagonistic antigen binding protein that specifically binds to the human glucagon receptor (GCGR), wherein the antagonistic antigen binding protein is a human anti-GCGR antibody which comprises the amino acid sequence encoding the heavy chain of SEQ ID NO: 51 and the amino acid sequence encoding the light chain of SEQ ID NO: 52.
US Pat. No. 10,765,738

COMBINATION OF ANTI-FGFR4-ANTIBODY AND BILE ACID SEQUESTRANT

Daiichi Sankyo Europe Gmb...

1. A pharmaceutical composition or kit comprising an anti-FGFR4 antibody in combination with a bile acid sequestrant, wherein (i) the anti-FGFR4 antibody comprises a heavy chain variable region according to SEQ ID NO: 54 and a light chain variable region according to SEQ ID NO: 62, and (ii) the bile acid sequestrant comprises colestyramine.
US Pat. No. 10,765,739

USE OF MIF AND MIF PATHWAY AGONISTS

Yale University, New Hav...

1. A method of increasing uptake of AMPK-mediated glucose into a cell, comprising administering a MIF agonist to a subject in need thereof,wherein the MIF agonist increases the uptake of AMPK-mediated glucose into the cell; and
wherein the subject has a condition in which increased AMPK activity is desirable selected from the group consisting of hypoxia, ischemia, and type 2 diabetes.
US Pat. No. 10,767,019

RESIN COMPOSITION, MICROPOROUS MEMBRANE, SEPARATOR AND SECONDARY BATTERY

ZEON CORPORATION, Chiyod...

1. A microporous film formed by using a resin composition, whereinthe resin composition contains a polymer (A) and a polymer (B), wherein a content of the polymer (A) is 1 to 80 wt% based on the total weight of the polymer (A) and the polymer (B);
polymer (A) is an alicyclic structure-containing hydrogenated polymer having a heat distortion temperature of 170° C. or higher and a melting point range from 180° C. to 350° C.;
polymer (B) is a polymer incompatible with the polymer (A) and having a heat distortion temperature of lower than 170° C.;
the microporous film has a sea-island structure constructed by dispersing the polymer (A) in the polymer (B);
an average diameter of island portions in the sea-island structure is from 0.05 to 100 ?m; and
an average diameter of micropores in the microporous film is 0.01 to 1 ?m.
US Pat. No. 10,765,740

SELECTIVELY ALTERING MICROBIOTA FOR IMMUNE MODULATION

SNIPR Technologies Limite...

1. A method for treating an infectious disease in a human patient, wherein the method comprises(a) exposing a microbiota in the patient to a guided nuclease to selectively target the genome of cells of a first species in the microbiota using the guided nuclease, wherein the first species is a bacterial or archaeal species; and simultaneously or sequentially administering to the patient an effective amount of an immunotherapy; and
(b) allowing the guided nuclease to cut one or more target nucleotide sequences comprised by first cells of a first strain of the first species, thereby killing the first cells or reducing the growth thereof, whereby the proportion of the first cells comprised by the microbiota is reduced;
wherein
(c) the selective targeting avoids targeting second cells comprised by the microbiota, wherein the second cells are of a different strain or a different species from the first cells, wherein the second cells are probiotic, commensal or symbiotic with humans; and
(d) the reducing of the proportion of the first cells modulates immune cells in the patient, whereby the efficacy of the immunotherapy is enhanced for treatment of the infectious disease in the patient.
US Pat. No. 10,767,020

CATALYST MASTERBATCH

BOREALIS AG, Vienna (AT)...

1. A catalyst masterbatch for cross-linking a polyolefin comprising cross-linkable silicon-containing groups comprisinga Brønsted acid and/or Brønsted acid anhydride (A); and
a polyolefin (B) containing Brønsted acid anhydride groups,
wherein the Brønsted acid and/or Brønsted acid anhydride (A) are selected from carboxylic acids, carboxylic acid anhydrides, sulphonic acid and/or sulphonic acid anhydrides;
wherein (A) is present in an amount of from 0.5 to 20 wt %, and
wherein (B) is present in an amount of from 15 to 99 wt % based on the total weight of the catalyst masterbatch.
US Pat. No. 10,765,741

METHODS FOR TREATING VEGF-EXPRESSING CANCER USING PREFORMED NANOPARTICLE COMPLEXES COMPRISING ALBUMIN-BOUND PACLITAXEL AND BEVACIZUMAB

Mayo Foundation for Medic...

1. A method for treating a VEGF-expressing cancer in a mammal, which method comprises:(a) confirming that the cancer to be treated expresses VEGF;
(b) obtaining a dry composition of preformed nanoparticle complexes comprising albumin-bound paclitaxel and an anti-VEGF antibody, wherein the ratio of albumin-paclitaxel to antibody is between 2:1 and 1:25, and wherein the anti-VEGF antibody is bevacizumab;
(c) forming an aqueous composition of said dry composition, said aqueous composition being suitable far injection into a mammal having cancer, and
(d) administering to said mammal an effective amount of the aqueous composition, wherein said administration treats said, cancer and wherein said preformed complexes retain antibody mediated VEGF binding specificity.
US Pat. No. 10,765,742

METHODS OF TREATING CD166-EXPRESSING CANCER

The Trustees of Columbia ...

1. A method comprising administering to a subject having a CD166-expressing cancer a therapeutically effective amount of an agent selected from the group consisting of full length ILT3, the extracellular domain of ILT3 and LT3Fc thereby treating the cancer, wherein the agent inhibits the interaction between ILT3 expressed on monocytes, macrophages, and dendritic cells with CD166 expressed on cancer cells, and the therapeutically effective amount significantly reduces the proliferation of the CD166-expressing cancer cells compared to respective pretreatment levels or significantly increases apoptosis of the CD166-expressing cancer cells compared to a pretreatment level.
US Pat. No. 10,765,743

ANTIBODIES BINDING AXL

1. A method of treating cancer comprising administering to a subject in need thereof a therapeutically effective amount of an immunoconjugate comprising a cytotoxic agent and an antibody which binds to human AXL and comprises a heavy chain variable (VH) region and a light chain variable (VL) region selected from the group consisting of:a) a VH region comprising the CDR1, CDR2, and CDR3 sequences of SEQ ID NOs: 36, 37, and 38, respectively; and a VL region comprising the CDR1, CDR2, and CDR3 sequences of SEQ ID NO: 39, GAS, and SEQ ID NO: 40, respectively,
b) a VH region comprising the CDR1, CDR2, and CDR3 sequences of SEQ ID NOs: 93, 94, and 95, respectively; and a VL region comprising the CDR1, CDR2, and CDR3 sequences of SEQ ID NO: 96, GAS, and SEQ ID NO: 97, respectively, and
c) a VH region comprising the CDR1, CDR2, and CDR3 sequences of SEQ ID NOs: 98, 99, and 100, respectively; and a VL region comprising the CDR1, CDR2, and CDR3 sequences of SEQ ID NO: 101, DAS, and SEQ ID NO: 102, respectively.
US Pat. No. 10,765,999

TREATMENT OF INDUSTRIAL WATER SYSTEMS

Ecolab USA Inc., Saint P...

1. A method of preparing an additive package having a base solvent and a plurality of concentrated active ingredients, the method comprising:dosing a volume of a first concentrated active ingredient of the plurality of concentrated active ingredients into the base solvent to form a first blend, wherein the first concentrated active ingredient comprises a first concentrated fluorophore;
monitoring a fluorescence response of the first concentrated fluorophore in the first blend as compared to a first fluorometric set point sensitive to concentration changes, wherein the dosing of the first concentrated active ingredient continues until the fluorescence response of the first concentrated fluorophore reaches the first fluorometric set point sensitive to concentration changes;
upon the fluorescence response of the first concentrated fluorophore reaching the first fluorometric set point, dosing a volume of a second concentrated active ingredient of the plurality of concentrated active ingredients into the first blend to form a second blend, wherein the second concentrated active ingredient is different than the first concentrated active ingredient, wherein the first blend does not include the second concentrated active ingredient, and
monitoring the fluorescence response of the first concentrated fluorophore in the second blend to a second fluorometric set point sensitive to concentration changes wherein the second fluorometric set point is different than the first fluorometric set point, wherein the dosing of the second concentrated active ingredient continues until the fluorescence response of the first concentrated fluorophore reaches the second fluorometric set point sensitive to concentration changes.
US Pat. No. 10,767,279

METHOD OF PREPARING WEAR AND CUT RESISTANT UHMWPE FIBERS

ZHEJIANG JINHAO NEW MATER...

1. A method of preparing wear and cut resistant UHMWPE fibers, comprising steps of:preparing a mother liquor by adding 0.1-0.5 parts of coupling agent A, 1-20 parts of nano additive B, 1-20 parts of additive C, 0.1-5 parts of sodium stearate, 0.1-8 parts of nano-sized dispersant, and 0.1-10 parts of antioxidant into 1000 parts of solvent oil, and processed by a 1000-20000 r/min high-speed rotating emulsifier for 2-6 hours, and a mixing temperature being controlled at 25° C.-100° C., wherein the nano additive B is selected from the group consisting of SiO2, TiO2, Al2O3, MgO, CaO, Si3N4, ZrO2, CrO3, montmorillonite, nano carbon black, graphite, tin antimony oxide, and carbon nanotube, and wherein the additive C is selected from the group consisting of a basalt staple fiber, a rockwool staple fiber, a slag cotton staple fiber, a glass staple fiber, an aluminum silicate cotton staple fiber, a polyester staple fiber, a carbon staple fiber, and an aramid staple fiber;
preparing a resin material which is an UHMWPE resin with a viscosity-average molecular weight of 2 millions-8 millions, adding 20-200 parts of the resin material into a ball grinder at a temperature controlled at 30° C.-100° C.;
adding the mother liquor into the ball grinder at a speed of 2 parts/minute;
blending and mixing the mother liquor and the resin material uniformly to form a mixed solution;
vacuuming the mixed solution in a sealed container for 2-6 hours; and
the mixed solution being extruded in sequence by a twin screw extruder, a metering pump, a spin beam, and processed by drafting, and drawing and winding formation.
US Pat. No. 10,767,535

METHOD FOR RECYCLING DENITRATION CATALYST

THE CHUGOKU ELECTRIC POWE...

1. A method for recycling a denitration catalyst, comprising:a step of spraying an aqueous solution with a pH of 7 or more onto a used denitration catalyst while the denitration catalyst is set in a denitration device to remove a surface of the denitration catalyst,
wherein the denitration catalyst contains 43 wt % or more of vanadium pentoxide and has a BET specific surface area of 30 m2/g or more, and the denitration catalyst after recycling is used for denitration at 200° C. or lower.
US Pat. No. 10,765,745

MULTIFUNCTIONAL NANOPARTICLE SYSTEMS AND METHODS FOR CANCER DIAGNOSIS AND COMBINATION THERAPY

Board of Regents, the Uni...

1. A method of diagnosing and/or treating a cancer; the method comprising:administering to a patient in need thereof a population of core-shell nanoparticles, the core-shell nanoparticles comprising:
a core component;
a shell component encapsulating the core component;
one or more radiosensitizers disposed in the core component; and
one or more chemotherapeutic agents disposed in the shell component,
wherein the core component is formed from one or more biodegradable polymers; and
wherein the shell component is formed from one or more stimuli responsive polymers that undergo a reversible phase transition in response to an external stimulus;
exposing the core-shell nanoparticles to the external stimulus;
releasing a portion of the chemotherapeutic agents in a burst release from the shell component in response to the exposure to the external stimulus; and
releasing a portion of the radiosensitizers in a sustained release from the core component in response to the exposure to the external stimulus.
US Pat. No. 10,767,025

PA/PET SEPARATION PROCESS

Ioniqa Techonolgies B.V.,...

1. Process for separating a composition comprising polyamide, polyester and at least one further additive, comprising the steps of:providing the composition, the composition having a density of 50-500 gr/dm3,
adding a branched or un-branched alcohol to the composition therewith forming a mixture, the alcohol having a boiling point above 150° C. (at 100 kPa),
heating the mixture to a temperature above 150° C. under reflux until polyamide is dissolved, while the polyester remains unaffected, therewith forming a slurry;
cooling the slurry;
which cooling comprises diluting the slurry by addition of hot water with a temperature of at least 80° C., during which polyamide is precipitated to particles, the amount of water being effective to precipitate the polyamide;
filtering the slurry over a first filter with a mesh larger than 0.2 ?m therewith forming a filtrate and a residue, wherein the residue comprises the polyester and the filtrate comprises the polyamide particles,
filtering the polyamide particles from the filtrate over a second filter to recover the polyamide, and
recovering the polyester for further processing for depolymerization of the polyester.
US Pat. No. 10,767,281

POLYESTER FIBER BLENDS AND METHODS OF MANUFACTURING SAME

ALADDIN MANUFACTURING COR...

1. A fiber comprising a polymer blend, said polymer blend comprising:a) about 1% by weight—about 15% by weight polytrimethylene terephthalate polymer; and
b) about 1% by weight—about 15% by weight polyethylene naphthalate polymer;
wherein the remainder of said polymer blend is polyethylene terephthalate polymer;wherein the fiber is a bulked continuous filament (BCF).
US Pat. No. 10,765,746

USE OF ANTI-CGRP ANTIBODIES AND ANTIBODY FRAGMENTS TO TREAT DIARRHEA IN SUBJECTS WITH DISEASES OR TREATMENTS THAT RESULT IN ELEVATED CGRP LEVELS

ALDERBIO HOLDINGS LLC, L...

1. A method of inhibiting, preventing or treating diarrhea in a subject comprising elevated levels of CGRP, wherein said elevated CGRP levels are associated with an acute condition comprising administering an effective amount of an anti-CGRP antibody or anti-CGRP antibody fragment, wherein the anti-CGRP antibody or antibody fragment comprises the variable light (VL) CDR1, CDR2, and CDR3 of SEQ ID NOs:55, 56 and 57, respectively, and the variable heavy (VH) CDR1, CDR2, and CDR3 of SEQ ID NOs:58, 59 and 60, respectively.
US Pat. No. 10,767,026

PROCESS FOR DEGRADING PLASTIC PRODUCTS

CARBIOS, Saint-Beauzire ...

1. A process for degrading a plastic product comprising at least one semi-crystalline thermoplastic polyester comprising the steps of:a) amorphizing at least partially said at least one semi-crystalline thermoplastic polyester of the plastic product by heating the plastic product at a temperature above the melting temperature (Tm) of said semi-crystalline thermoplastic polyester, and further cooling the plastic product at a temperature below the crystallization temperature (Tc) of said semi-crystalline thermoplastic polyester, and
b) depolymerizing said at least partially amorphized polyester of the plastic product by contacting the plastic product with a depolymerase able to depolymerize said at least partially amorphized polyester into monomers and/or oligomers.
US Pat. No. 10,767,282

METHOD FOR MANUFACTURING CARBON NANOSTRUCTURE, AND DEVICE FOR MANUFACTURING CARBON NANOSTRUCTURE

SUMITOMO ELECTRIC INDUSTR...

1. A method for manufacturing a carbon nanostructure, comprising:a preparation step of preparing a substrate containing a carburizable metal as a main component; and
a carbon nanostructure growth step of supplying a carbon-containing gas while heating the substrate,
wherein the carbon nanostructure growth step includes gradually cleaving a heated portion of the substrate.
US Pat. No. 10,765,747

METHODS OF REDUCING AGGREGATION OF IL-1RA

SWEDISH ORPHAN BIOVITRUM ...

1. A method of reducing aggregation of an aggregating interleukin-1 receptor antagonist (IL-1ra) in an aqueous composition comprisingincubating the aqueous composition comprising the IL-1ra with at least one accessory molecule at a concentration sufficient to reduce aggregation of the IL-1ra for at least two hours at 25 to 45° C., and
determining reduced aggregation of the IL-1ra in the aqueous composition by measuring the optical density at 405 nm of the aqueous composition after at least two hours of incubation at 30 to 45° C., wherein the optical density of the aqueous composition comprising the IL-1ra is less than 60% of the optical density of an aqueous composition comprising the IL-1ra without incubating with the accessory molecule, and
wherein the at least one accessory molecule is selected from the group consisting of (1) a sugar at a concentration of from 1 to 2 percent, wherein the sugar is sucrose, glycerol, or sorbitol, (2) a multiple-charge anion, wherein the multiple-charge anion is 1 to 20 mM pyrophosphate or 1 to 20 mM citrate, and (3) a lysine-reactive accessory molecule or an arginine-reactive accessory molecule, selected from the group consisting of the three compounds from 6-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)hexanoic acid (NBD-X), methyl acetyl phosphate (MAP), and citraconic anhydride.
US Pat. No. 10,767,028

COMPOUNDED RUBBER HAVING IMPROVED THERMAL TRANSFER

Cabot Corporation, Bosto...

1. A compounded elastomeric composition comprising:an elastomeric resin;
a first carbon black;
a second carbon black different from the first carbon black, wherein the second carbon black is a partially crystallized carbon black having an OAN structure of greater than 120 cm3/100 g and less than 200 cm3/100 g, a surface energy of less than 10 mJ/m2 and a Raman microcrystalline planar size (La) of greater than or equal to 25 ? and less than or equal to 50 ?.
US Pat. No. 10,766,005

NANOSTRUCTURED POLYELECTROLYTES FOR ION-SELECTIVE MEMBRANES

1. A method to fabricate an ion-selective membrane, comprising the steps of:providing a nanoporous membrane; and
layer-by-layer depositing at least one polyelectrolyte bilayer on at least one side of the nanoporous membrane, wherein the polyelectrolyte bilayer comprises a cationic polymer layer and an anionic polymer layer; and either
chemically crosslinking or charge-neutralizing the cationic polymer, thereby decreasing a cationic fixed charge in the polyelectrolyte bilayer; or
chemically crosslinking or charge-neutralizing the anionic polymer, thereby decreasing an anionic fixed charge in the polyelectrolyte bilayer; or
chemically crosslinking the cationic polymer with the anionic polymer, thereby decreasing both a cationic fixed charge and an anionic fixed charge in the polyelectrolyte bilayer.
US Pat. No. 10,766,773

GRAPHITE SHEET HAVING EXCELLENT THERMAL CONDUCTIVITY AND METHOD FOR PREPARING THE SAME

PI Advanced Materials Co....

1. A method for preparing a high-performance graphite sheet, comprising:providing a polyimide film containing a first filler having an average particle diameter of 2.0 ?m to 2.5 ?m, and a second filler having an average particle diameter of 1.0 ?m to 1.6 ?m; and
carbonizing and graphitizing the polyimide film to obtain the graphite sheet,
wherein the thermal conductivity of the graphite sheet is at least 1,400 W/m·K.
US Pat. No. 10,765,750

PHARMACEUTICAL COMPOSITION CONTAINING PYRIDYLAMINOACETIC ACID COMPOUND

SANTEN PHARMACEUTICAL CO....

1. A pharmaceutical composition comprising isopropyl (6-{[4-(pyrazol-1-yl)benzyl](pyridin-3-ylsulfonyl)aminomethyl}pyridin-2-ylamino)acetate or a salt thereof and a nonionic surfactant, which further comprises edetic acid or a salt thereof,wherein the nonionic surfactant includes polyoxyethylene castor oil,
wherein the pharmaceutical composition does not comprise sorbic acid;
wherein the content of the nonionic surfactant is in a range of 0.001 to 5% (w/v), and
wherein the content of the edetic acid or a salt thereof is in a range of 0.001 to 1% (w/v).
US Pat. No. 10,767,031

COTTONSEED OIL BASED LIQUID COLOR COMPOSITION AND PLASTICS COLORING METHOD USING THE SAME

1. A method for making colored plastic parts comprising plastic resin being selected from the group comprising acrylic, nylon, acrylonitrile butadiene styrene, polycarbonate, polybenzimidazole, polyether sulfone, polyetherether ketone, polyethermide, polyethylene, polypropylene, polyethylene sulfide, polyphenylene oxide, polystyrene, polyvinyl chloride, polytetrafluoroethylene, the method comprising:a) providing a collection of pigments;
b) providing a quantity of a liquid carrier consisting of cottonseed oil;
c) from the collection of pigments creating a plurality of separate single pigment liquid dispersions in separate portions of the cottonseed oil;
d) blending one or more of the plurality of separate single pigment liquid dispersions to create a liquid blend of a desired color;
e) combining the liquid blend with the selected plastic resin;
f) molding the resin-liquid blend combination into the colored plastic parts.
US Pat. No. 10,765,752

SOLID COMPOSITION COMPRISING IRON FOR USE IN IRON DEFICIENT CONDITIONS

ALESCO S.R.L., Pisa (IT)...

1. A solid composition comprising an iron (Ill) salt, said iron (Ill) salt being ferric pyrophosphate in an amount from 30% to 70% by weight, sucrose esters or sucresters E473, wherein said sucrose esters or sucresters E473 are in an amount from 10% to 30% by weight, and a non-hydrolyzed lecithin wherein said lecithin is in an amount from 0.1% to 1.5% by weight.
US Pat. No. 10,766,776

SURFACE-MODIFIED NANODIAMOND, ORGANIC SOLVENT DISPERSION THEREOF, AND METHOD FOR PRODUCING SURFACE-MODIFIED NANODIAMOND

DAICEL CORPORATION, Osak...

1. A surface-modified nanodiamond comprising:a nanodiamond; and
a group being bound to a particulate surface of the nanodiamond and represented by formula (1):
—NHCOR   (1)wherein R is an organic group having a carbon atom at a binding site with a neighboring carbonyl carbon atom indicated in the formula; and the left end, in the formula, of the group serves to form bonding to the nanodiamond.
US Pat. No. 10,765,496

LITHIUM DISILICATE GLASS-CERAMIC, METHOD FOR PRODUCTION THEREOF AND USE THEREOF

DEGUNDENT GMBH, Hanau (D...

1. A lithium silicate glass ceramic that includes at least 10 wt % ZrO2, from 55 to 70 wt % SiO2, and from 10 to 15 wt % LiO2 and having a main crystal phase consisting of lithium disilicate crystal.
US Pat. No. 10,765,753

POLYMER NANOPARTICLE FREEZE-DRIED PRODUCT, AND PREPARATION METHOD THEREFOR

SAMYANG BIOPHARMACEUTICAL...

1. A method for preparing lyophilizate of polymeric nanoparticle by lyophilization process of a solution of polymeric nanoparticle,wherein the solution of polymeric nanoparticle comprises an amphiphilic block copolymer consisting of a hydrophilic block (A) and a hydrophobic block (B) in A-B, A-B-A or B-A-B form; a polylactic acid derivative having carboxyl terminal group; a lyophilization aid; and a poorly water-soluble drug which is paclitaxel or docetaxel,
wherein the solution of polymeric nanoparticle has a polymer concentration of 120 mg/ml or lower,
wherein the lyophilization process comprises:
a) a first freezing step where the solution of polymeric nanoparticle is frozen to a temperature in the range of ?10 to ?45° C.;
b) an annealing step where the resulting product of the first freezing is heated to a temperature in the range of ?25 to 0° C.;
c) a second freezing step where the resulting product of the annealing is frozen to a temperature in the range of ?10 to ?45° C.;
d) a primary drying step where the resulting product of the second freezing is dried at a temperature of lower than 0° C. under reduced pressure;
e) a secondary drying step where the resulting product of the primary drying is dried at a temperature of 0° C. or higher under reduced pressure; and
f) introducing the resulting product into a vial, and sealing the vial in vacuo; and
wherein the lyophilizate of polymeric nanoparticle is reconstituted within 5 minutes when reconstituted with an aqueous solvent under atmospheric pressure;
the amount of the lyophilization aid is 10 to 60% by weight, based on the total dry weight of the lyophilizate of polymeric nanoparticle;
the hydrophilic block (A) is selected from the group consisting of polyethylene glycol, monomethoxypolyethylene glycol, polyvinyl pyrrolidone, polyvinyl alcohol and polyacrylamide; and the hydrophobic block (B) is selected from the group consisting of polylactide, polyglycolide, polydioxan-2-one, polycaprolactone, polylactic-co-glycolide, polylactic-co-caprolactone, polylactic-co-dioxan-2-one and polyglycolic-co-caprolactone;
the hydrophilic block (A) has a number average molecular weight of 500 to 50,000 Daltons; and the hydrophobic block (B) has a number average molecular weight of 500 to 50,000 Daltons;
the polylactic acid derivative having carboxyl terminal group has a number average molecular weight of 500 to 5,000 Daltons; and
the lyophilizate has an average pore size of 70 ?m or greater.
US Pat. No. 10,765,754

COMPOSITIONS AND METHODS RELATED TO INHIBITION OF RESPIRATORY SYNCYTIAL VIRUS ENTRY

Navigen, Inc., Salt Lake...

1. An isolated D-peptide comprising the amino acid sequence of SEQ ID NO:42, wherein the amino acids of the D-peptide have a D-configuration with the exception of glycine and the D-peptide is capable of interacting with the N-trimer groove of respiratory syncytial virus (RSV) F protein.
US Pat. No. 10,767,034

PNEUMATIC TIRE

1. A pneumatic tire having a tread comprising a vulcanizable rubber composition comprising, based on 100 parts by weight of elastomer (phr),(A) from about 30 to about 50 phr of a first solution polymerized styrene-butadiene rubber having a glass transition temperature (Tg) ranging from ?80° C. to ?50° C. and functionalized with an alkoxysilane group and at least one functional group selected from the group consisting of primary amines and thiols;
(B) from about 30 to about 50 phr of a second solution polymerized styrene-butadiene rubber having a glass transition temperature (Tg) ranging from ?40° C. to ?10° C. and functionalized with an alkoxysilane group and at least one functional group selected from the group consisting of primary amines and thiols;
(C) from 0 to about 40 phr of a polyisoprene having a cis 1,4 content greater than 95 percent selected from the group consisting of natural rubber and synthetic polyisoprene;
(D) from 20 to 60 phr of a hydrocarbon resin having a Tg of at least 30° C.;
(E) from 40 to 80 phr of an oil; and
(F) from 120 to 180 phr of silica.
US Pat. No. 10,767,290

TAPE AND PRODUCTS CONTAINING THE SAME

DSM IP ASSETS B.V., Heer...

1. A fibrous tape comprising fused polymeric fibers, wherein at least 75 mass % of the fused polymeric fibers are oriented so as to be substantially in parallel along a common direction, and whereinthe polymeric fibers have a fiber length and abutting ones of the polymeric fibers are fused to each other over an abutting length of at least 50% of the fiber length, and wherein
the fibrous tape has a tape thickness from 1 ?m to 200 ?m, a tape width, and a coefficient of variation (CV) of the tape thickness across the tape width of at most 6%, wherein the CV of the tape thickness is calculated by:
(i) obtaining a cross section of the tape by embedding the tape in epoxy resin and cutting slices of the embedded tape-resin system;
(ii) selecting an enlargement using a microscope such that the width of the tape is equal to about 40 times the thickness of the tape;
(iii) taking 5 measurements of the local thickness of the tape, evenly distributed across the width of the tape; and
(iv) dividing the standard deviation of the 5 measurements by the average of the 5 measurements.
US Pat. No. 10,765,755

PREPARATION AND CHARACTERIZATION OF METHYLENE BLUE NANOPARTICLES FOR ALZHEIMER'S DISEASE AND OTHER TAUOPATHIES

University of South Flori...

1. A nanoparticle drug composition comprising:at least one nanoparticle comprising a poly(lactic-co-glycolic acid) polymer conjugated to polyethylene glycol (PEG) linked to a hydrophilic group wherein the nanoparticle is coated with glutathione; and
a hydrophilic pharmaceutically active agent encapsulated within the at least one nanoparticle at an entrapment efficiency of about 19% wherein the hydrophilic pharmaceutically active agent is methylene blue;
wherein the nanoparticle drug composition is generated by a process consisting essentially of:
dissolving or diluting the poly(lactic-co-glycolic acid) polymer conjugated to the polyethylene glycol (PEG) linked to the hydrophilic group and a predetermined quantity of the hydrophilic pharmaceutically active agent in an amount of acetone and an amount of ethanol to form a solution;
adding the solution to a polyvinyl alcohol (PVA) solution to form an emulsion;
evaporating the acetone from the emulsion wherein upon evaporation of the acetone, at least one nanoparticle is generated;
centrifuging the emulsion to remove unencapsulated hydrophilic pharmaceutically active agent and the PVA; and
coating the at least one nanoparticle with the glutathione.
US Pat. No. 10,766,779

ECONOMICALLY VIABLE PROCESS FOR PRODUCING ORGANICALLY MODIFIED LYO- OR AEROGELS

Wacker Chemie AG, Munich...

2. A process for producing lyogels or aerogels, said process comprising the following stepsi) emulsifying a basic, polar phase comprising water and starting materials for silicatic gels in an apolar phase comprising a water-immiscible precursor of an active silylating agent,
ii) commencing gel formation and aging by lowering a pH with a chlorosilane, and then
iii) lowering the pH to commence silylation and solvent exchange.
US Pat. No. 10,767,036

POLYOLEFIN COMPOSITION FOR FIBERS

Basell Poliolefine Italia...

1. A polyolefinic fiber comprising:from 2 wt % to 20 wt % relative to the total weight of the fiber of a polyolefin composition comprising:
A) 5-35% by weight of a propylene homopolymer or a propylene ethylene copolymer containing 90% by weight or more of propylene units; component A) containing 10% by weight or less of a fraction soluble in xylene at 25° C. (XSA), both the amount of propylene units and of the fraction XSA being referred to the weight of A);
B) 20-50% by weight; of a copolymer of ethylene and a C3-C8 alpha-olefin containing from 0.1% to 20% by weight of alpha-olefin units and containing 25% by weight or less; of a fraction soluble in xylene at 25° C. (XSB), both the amount of alpha-olefin units and of the fraction XSB being referred to the weight of (B); and
C) 30-60% by weight of a copolymer of ethylene and propylene containing from 25% to 75% by weight of ethylene units and containing from 40% to 95% by weight of a fraction soluble in xylene at 25° C. (XSC), both the amount of ethylene units and of the fraction XSC being referred to the weight of (C);
the amounts of (A), (B) and (C) being referred to the total weight of (A)+(B)+(C), the sum of the amount of (A)+(B)+(C) being 100.
US Pat. No. 10,765,500

TEMPORARILY STIFFENED MESH PROSTHESES

MEDTRONIC, INC., Minneap...

1. A medical prosthesis comprising:a surgical mesh with a coating, the coating including a first layer and a second layer, the first layer being positioned between the mesh and the second layer,
wherein the coating is applied to the mesh without substantially altering a porosity of the mesh,
wherein the first layer comprises a first polymer and the second layer comprises a second polymer that is different than the first polymer, and
wherein at least one of the polymers comprises a tyrosine-derived polyarylate.
US Pat. No. 10,765,757

MUCOSAL DELIVERY OF THERAPEUTIC MOLECULES, PROTEINS, OR PARTICLES COUPLED TO CERAMIDE LIPIDS

1. A method of delivering an agent into cells or across a mucosal surface, comprising contacting a complex of a delivery vehicle and the agent with the cells or the mucosal surface, under conditions appropriate for uptake of the delivery vehicle or the agent of interest into the cell or absorption of the delivery vehicle or the agent of interest across the mucosal surface,wherein the delivery vehicle comprises a glycosphingolipid that forms a complex with the agent to be delivered, wherein the glycosphingolipid comprises a ceramide consisting of a sphingosine coupled with (a) a short chain fatty acid (C4-C12) or (b) a long chain fatty acid (C14-C28) comprising at least one cis double bond between two carbon atoms and wherein the agent to be delivered is covalently attached to the oligosaccharide of the glycosphingolipid.
US Pat. No. 10,766,781

TIN-CONTAINING ZEOLITIC MATERIAL HAVING A BEA FRAMEWORK STRUCTURE

BASF SE, (DE)

1. A tin-containing zeolitic material having framework type BEA, obtained by a process comprising(i.1) providing an aqueous synthesis mixture comprising a boron source, a silicon source, and a BEA structure directing agent;
(i.2) subjecting the synthesis mixture provided in (i) to hydrothermal pre-crystallization conditions;
(i.3) adding a tin source to the mixture obtained from (i.2);
(i.4) subjecting the aqueous synthesis mixture obtained from (i.3) to hydrothermal crystallization conditions, obtaining a tin-containing zeolitic material having framework type BEA comprised in its mother liquor.
US Pat. No. 10,765,759

METHODS OF TREATING AN OCULAR DISEASE OR DISORDER

The Regents of the Univer...

1. A method of treating an ocular disease or disorder in an individual, the method comprising administering to the individual an effective amount of a conjugate comprising:a) a biologically active polypeptide having a molecular weight of from about 5 kDa to about 250 kDa, wherein the biologically active polypeptide is a single-chain Fv (scFv) anti-vascular endothelial growth factor (VEGF) antibody or a single-domain camelid (VHH) anti-VEGF antibody; and
b) a biocompatible polymer comprising hyaluronic acid having a molecular weight of from about 500 kDa to about 1 MDa,
wherein the polypeptide is covalently linked to the polymer directly or via a linker, and wherein the molar ratio of the biologically active polypeptide to the polymer is at least 25:1,
wherein said administering is by intravitreal administration.
US Pat. No. 10,766,783

MAGNESIUM OXIDE-CONTAINING SPINEL POWDER AND METHOD FOR PRODUCING SAME

TATEHO CHEMICAL INDUSTRIE...

1. A magnesium oxide-comprising oxide containing spinel powder, which has a volume-based cumulative 50% particle diameter (D50) in a range of from 0.30 to 10.00 ?m,a ratio (D90-D50)/(D50-D10) of a difference between a volume-based cumulative 90% particle diameter (D90) and D50 to a difference between D50 and a volume-based cumulative 10% particle diameter (D10) in a range of from 1.0 to 5.0, and
a composition ratio of Mg and Al, in terms of an oxide equivalent content, of 50 to 90% by weight of MgO and 10 to 50% by weight of Al2O3, based on 100% by weight of both of MgO and Al2O3
wherein D50, D90, and D10 are measured by a laser diffraction scattering particle size distribution measurement.
US Pat. No. 10,767,039

THERMOPLASTIC RESIN COMPOSITION

LG CHEM, LTD., Seoul (KR...

1. A resin composition comprising:(A) 10 parts by weight to less than 30 parts by weight of a butadiene-based graft copolymer including 30 wt % to 70 wt % of a butadiene-based rubber polymer core, and 30 wt % to 70 wt % of a graft shell having a vinyl cyanide monomer-derived unit and an aromatic vinyl monomer-derived unit;
(B) 5 parts by weight or more to less than 30 parts by weight of an acrylate-based graft copolymer including 30 wt % to 70 wt % of an acrylate-based rubber polymer core, and 30 wt % to 70 wt % of a graft shell having a vinyl cyanide monomer-derived unit and an aromatic vinyl monomer-derived unit;
(C) 35 parts by weight to 65 parts by weight of a vinyl cyanide-aromatic vinyl-based copolymer;
(D) 1 part by weight to 10 parts by weight of an ethylene-alkyl acrylate-based copolymer elastomer based on the total 100 parts by weight of (A), (B), and (C); and
(E) 1 part by weight to 10 parts by weight of a polyester-based elastomer.
US Pat. No. 10,766,016

SORBENT COMPOSITION FOR USE IN A FLUE GAS TRAIN INCLUDING A BAGHOUSE

ADA Carbon Solutions, LLC...

1. A sorbent composition that enhances baghouse unit performance, the sorbent composition comprising:a first particulate sorbent comprising powdered activated carbon and having a median particle diameter of not greater than about 30 ?m and at least about 20 ?m; and
a second particulate sorbent comprising powdered activated carbon and having a median particle diameter of not greater than about 20 ?m and at least about 8 ?m, wherein the median particle diameter of the second particulate sorbent is at least about 5 ?m less than the median particle diameter of the first particulate sorbent,
wherein a pressure drop as measured in a permeability test under an applied normal stress of 15 kPa at an air velocity of 0.5 mm/s is not greater than about 78 mBar.
US Pat. No. 10,767,040

THERMOSETTING EPOXY RESIN COMPOSITIONS USEFUL AS STRUCTURAL REINFORCEMENT OR STRUCTURAL FOAM

SIKA TECHNOLOGY AG, Baar...

20. A fully cured epoxy resin composition obtained by heating a thermosetting epoxy resin composition according to claim 1 to a temperature of 100-220° C.
US Pat. No. 10,765,761

NUCLEIC ACID CONDENSING PEPTIDE, NUCLEIC ACID CONDENSING PEPTIDE SET, NUCLEIC ACID DELIVERY CARRIER, NUCLEIC ACID DELIVERY METHOD, CELL PRODUCTION METHOD, CELL DETECTION METHOD AND KIT

KABUSHIKI KAISHA TOSHIBA,...

1. A nucleic acid condensing peptide comprising:a first sequence RRRRRR at one terminal, a second sequence RQRQR at another terminal,
none or one or more intermediate sequences comprising RRRRRR or RQRQR between the first sequence and the second sequence, and
two or more neutral amino acids between two adjacent sequences of the first sequence, the second sequence and the intermediate sequence.
US Pat. No. 10,766,017

METHOD FOR OBTAINING HYDROCARBON ABSORBER AND PRODUCT OBTAINED

1. A method for Obtaining Hydrocarbon Absorber and Product Obtained, comprising the following steps:performing a withdrawal and transversal cut of a stem from an Australian king palm (Archontophoenix cunninghamiana), originating tablets of approximately 5 cm in thickness and various diameters having their moisture removed through environmental exposure; grinding dried pastilles in a hammer mill and dismembering them so that their fibers can be removed, and then drying, after dismembering, to form pellets, wherein the pellets originate two types of fibers, a finer type in powder form having a different size, and a long fiber type having a length of about 5 cm; then the two types of fiber have their moisture removed in circular dryer and/or sieve and then the two types of fiber are separated; after separation the powdered fiber is exposed to the sun so that its drying occurs and the powder becomes an absorber, which is packaged and stored.
US Pat. No. 10,765,762

HUMANIZED MODEL OF KIDNEY AND LIVER DISORDERS

Regeneron Pharmaceuticals...

1. A method for assessing the in vivo therapeutic efficacy of an agent for use in a treatment of a complement-related nephropathy, the method comprising:(a) administering the agent to a mouse whose genome comprises a replacement at an endogenous mouse C3 locus to form a modified C3 gene,
wherein the replacement is (i) a replacement of a mouse gene sequence comprising exon 1 through exon 41 of the mouse C3 gene with a nucleic acid sequence comprising exon 1 through exon 41 of the human C3 ene, or (ii) a replacement of a mouse gene sequence comprising exon 2 through exon 41 of the mouse C3 gene with a nucleic acid sequence comprising exon 2 through exon 41 of the human C3 gene,
wherein expression of the modified C3 gene is under control of mouse regulatory elements at the endogenous mouse C3 locus, wherein the mouse spontaneously exhibits one or more symptoms of the complement-related nephropathy; and
(b) measuring the one or more symptoms of the complement-related nephropathy in the mouse, and categorizing the agent as a therapeutic agent for treating the complement-related nephropathy when the agent inhibits the one or more symptoms of the nephropathy compared to control mice who have not been administered the agent,
wherein the one or more symptoms of the nephropathy are selected from the group consisting of
(i) one or more of glomerulonephritis, basophilic tubules, sclerotic glomeruli, dilated tubules with protein casts, mesangial matrix expansion, glomerular hypertrophy, mononuclear interstitial inflammation,
(ii) C3 protein deposition in the kidney,
(iii) deposition of C5b-9 membrane attack complexes in the kidney,
(iv) one or more of elevated blood urea nitrogen (BUN), serum lipase, serum cystatin C, or serum non-high density lipoproteins, and
(v) increased urinary albumin or C5a.
US Pat. No. 10,767,042

POLYLACTIDE BASED COMPOSITIONS

1. A process for preparing a composition comprising:contacting (a) at least one first polymer wherein the first polymer is a polylactide-urethane-polybutadiene block copolymer or a mixture of a polylactide-urethane-polybutadiene block copolymer and a PLA-PB block copolymer;
with (b) at least one second polymer selected from polylactide, polylactide-urethane, or a mixture thereof;
wherein the composition comprises;
from 20% to 50% by weight of said first polymer based on the total weight of the composition and from 50% to 80% by weight of said second polymer based on the total weight of the composition.
US Pat. No. 10,766,019

OLEFIN METATHESIS REACTION CATALYST AND PREPARATION METHOD THEREFOR

Korea Research Institute ...

1. A method of olefin metathesis comprising the step of contacting olefin with an olefin metathesis catalyst, in which rhenium (Re) oxide or molybdenum (Mo) oxide is supported on the surface-modified mesoporous silica support which is surface modified with an oxide of an element selected from the group consisting of Al, Nb, Fe, Co, Zn, Ga and Sn, and characteristically prepared by the processes of:reacting the —OH group existing on the surface of the mesoporous silica support with a compound in which 1˜4 C1-C5 alkoxy groups are linked to the element selected from the group consisting of Al, Nb, Fe, Co, Zn, Ga and Sn in order to graft the compound on the surface of the support; and eliminating the unreacted compounds from the support, followed by calcining; and
impregnating the mesoporous silica support with a rhenium (Re) oxide or molybdenum (Mo) oxide precursor solution, followed by calcining, to convert the rhenium (Re) oxide or molybdenum (Mo) oxide precursor to rhenium (Re) oxide or molybdenum (Mo) oxide on the surface modified silica support;the catalyst additionally containing one or more platinum group metals selected from the group consisting of Pt, Pd and Rh, at a concentration of 3 weight part or less, by total weight of the catalyst.
US Pat. No. 10,766,022

HYDROCARBON CONVERSION CATALYST COMPOSITION

Shell Oil Company, Houst...

1. A catalytic dewaxing process for reducing the pour point of a wax-containing feedstock, said catalytic dewaxing process comprises:contacting under dewaxing conditions said wax-containing feedstock, having a 10% distillation point at 200° C. as measured by ASTM D-2887-93, with a dewaxing catalyst composition, wherein said dewaxing conditions include a contacting temperature in the range of from 250 to 400° C., a contacting pressure in the range of from 5×105 to 200×105 Pa, and a liquid hourly space velocity in the range of from 0.1 to 10 hr ?1, and thereby providing a reduction of the pour point of said wax-containing feedstock by at least 10° C.;
wherein said dewaxing catalyst comprises a dealuminated dried and calcined extrudate, wherein said extrudate, before drying and calcination, comprises a binder that is essentially free of alumina and which comprises both a silica powder, wherein said silica powder comprises powder particles having a mean diameter between 10 ?m and 200 ?m, and a silica sol; EU-2 zeolite, wherein said EU-2 zeolite has a silica-to-alumina molar bulk ratio before the dealumination of said dried and calcined extrudate in the range of from 100 to 210; a plasticising agent; and water in an amount of at least 35% and not exceeding 60% by weight of the extrudate before drying and calcination; and
a catalytic metal selected from the group consisting of platinum, palladium and nickel;
wherein the dealumination of said dried and calcined extrudate is done by contacting said dried and calcined extrudate with an aqueous solution of fluorosilicate salt having a concentration of at least 0.005 mole of fluorosilicate salt/liter and at most 0.5 mole of fluorosilicate salt/liter and at a temperature in the range of from 10° C. to 120° C., and
wherein the amount of said EU-2 zeolite present in said catalyst composition is at least 15% wt. of said catalyst composition; and
wherein the EU-2 zeolite is in the form of EU-2 zeolite particles, where the average aluminum concentration of the EU-2 zeolite particles is at least two times the aluminum concentration at the surface of the particles.
US Pat. No. 10,767,046

POLYAMIDE RESIN MOLDED BODY

ASAHI KASEI KABUSHIKI KAI...

1. A polyamide resin molded body formed by a resin composition comprising:a (A) polyamide resin; and
a (B) fluorine series resin being particles dispersed in the (A) polyamide resin;
wherein
the content of the (B) fluorine series resin being from 1 to 15 parts by mass with respect to 100 parts by mass of the (A) polyamide resin;
the number average particle diameter of the (B) fluorine series resin particles being 0.8 ?m or less and at least one of (i) and (ii) is satisfied:
(i) particles having particle diameters of 0.8 ?m or greater of the dispersed fluorine resin particles (B)
being one or more selected from the group consisting of primary particles, secondary particles aggregated and maintained in the form of primary particles, and secondary particles aggregated and not maintained in the form of primary particles, and
numerically consisting of no less than 60% of secondary particles aggregated and maintained in the form of primary particles,
(ii) the degree of crystallinity of the dispersed (B) fluorine series resin being 42 J/g or greater.
US Pat. No. 10,767,047

REINFORCED POLYAMIDE MOLDING COMPOUNDS HAVING LOW HAZE AND MOLDED BODIES THEREFROM

1. A polyamide molding compound comprising the following components:(A) 50 to 95 wt % of a mixture consisting of the polyamides (A1) and (A2), wherein
(A1) is at least one transparent, semi-aromatic polyamide having at least 25 mol % of monomers having aromatic structural units, related to the total quantity of diamines and dicarboxylic acids in the polyamide (A1) that is amorphous or microcrystalline; and
(A2) is at least one transparent polyamide having less than 25 mol % of monomers having aromatic structural units, related to the total quantity of diamines and dicarboxylic acids in the polyamide (A2) that is amorphous or microcrystalline;
(B) 5 to 50 wt % of at least one glass filler having a refractive index in the range from 1.510 to 1.539; and
(C) 0 to 10 wt % of at least one additive;
wherein the weight proportions of the components (A) to (C) add up to 100% by weight;
wherein the content of (A1) in the mixture (A) is >50 wt %, if the ratio is ?2/?1>1 and the content of (A2) in the mixture (A) is >50 wt %, if the ratio is ?2/?1?1, where ?1=n (A1)?n(B) applies and ?2=n(B)?n(A2) applies; n being the refractive index measured according to ISO 489 (1999-04),
wherein the transparent polyamides (A1) and (A2) have a transparency of at least 90% and a haze of at most 3%; and
wherein the mixture (A) has a transparency of at least 88% and a haze of at most 5%.
US Pat. No. 10,767,048

REINFORCED POLYAMIDE MOLDING COMPOUNDS HAVING LOW HAZE AND MOLDED BODIES THEREFROM

1. A polyamide molding compound comprising the following components:(A) 50 to 95 wt % of a mixture consisting of the polyamides (A1) and (A2), wherein
(A1) is at least one transparent, semi-aromatic polyamide having more than 35 mol % of monomers having aromatic structural units, related to the total quantity of diamines and dicarboxylic acids in the polyamide (A1) that is amorphous or microcrystalline; and
(A2) is at least one transparent, semi-aromatic polyamide having at most 35 mol % of monomers having aromatic structural units, related to the total quantity of diamines and dicarboxylic acids in the polyamide (A2) that is amorphous or microcrystalline;
(B) 5 to 50 wt % of at least one glass filler having a refractive index in the range from 1.540 to 1.600; and
(C) 0 to 10 wt % of at least one additive;
wherein the weight proportions of the components (A) to (C) add up to 100% by weight;
wherein the content of (A1) in the mixture (A) is >50 wt %, if the ratio is ?2/?1>1 and the content of (A2) in the mixture (A) is >50 wt %, if the ratio is ?2/?1?1, where ?1=n(A1)?n(B) and ?2=n(B)?n(A2) applies; n being the refractive index measured according to ISO 489 (1999 April),
wherein the polyamide molding compound has a transparency of at least 80% and a haze of maximum 40%;
wherein the transparency and haze of the polyamide molding compound are measured in accordance with ASTM D1003 on a molded plate of the polyamide molding compound having a dimension of 60 mm×60 mm×2 mm.
US Pat. No. 10,766,025

PREPARATION AND USE OF COPPER CONTAINING HYDROGENATION CATALYST

Shell Oil Company, Houst...

1. A process for preparing a catalyst useful in the hydrogenation of methyl phenyl ketone (MPK) to methyl phenyl carbinol, which process comprises:mixing a copper salt containing solution with a composition containing a silicate salt selected from the group consisting of sodium silicate and calcium silicate resulting in a mixture containing a precipitated solid;
recovering the precipitate solid from the mixture;
subjecting the recovered precipitated solid to a temperature in the range of from 150 to 500° C. to provide a thermally treated precipitated solid;
mixing the thermally treated precipitated solid with a silica sol containing silica particles having an average size in the range of from 1 to 100 nm to provide a second mixture;
forming the second mixture into a shaped body; and
drying the shaped body at a temperature in the range of from 80 to 160° C. followed by subjecting the shaped body to a temperature in the range of from 150 to 500° C. to yield the catalyst.
US Pat. No. 10,766,026

ANION EXCHANGE STATIONARY PHASES BASED ON CROSSLINKED HYDROXYALKYLAMINE LAYER AND GLYCIDOL

Dionex Corporation, Sunn...

1. An anion exchange stationary phase formed by a method comprising:reacting a polyepoxide with a primary amine to form a base condensation polymer layer on a negatively charged substrate particle;
reacting the base condensation polymer layer with a number of reaction cycles to form a crosslinked ethanolamine polymer layer, in which the number of reaction cycles ranges from three to ten and each reaction cycle includes a polyepoxide treatment followed by an ethanolamine treatment; and
reacting the crosslinked ethanolamine polymer layer with a glycidol treatment.
US Pat. No. 10,767,306

WATER BASED LIQUID FIRE RETARDANT FOR USE IN CELLULOSE INSULATION

1. A method of producing a fire-retarded cellulose fiber material, comprising:providing an aqueous fire-retardant composition comprising phosphoric acid, ammonium sulfate and water, and optionally, one or more non-fire retardant additives, the aqueous fire-retardant composition having a pH of 1.75 to 2.6, and the phosphoric acid and the ammonium sulfate having a weight ratio of 1:19 to 5:15;
applying the aqueous fire-retardant composition to a cellulose material to produce a wetted, fire retardant-treated cellulose material comprising from 5 wt % to 15 wt % of a sum weight of the phosphoric acid and the ammonium sulfate, based on a total weight of the wetted, fire retardant-treated cellulose material;
drying the wetted, fire retardant-treated cellulose material to produce a dried, fire retardant-treated cellulose material comprising phosphoric acid and ammonium sulfate absorbed, adsorbed and/or adhered to the cellulose material;
processing the dried, fire retardant-treated cellulose material in size to produce a reduced size, fiberized, fire-retarded cellulose fiber material; and
removing dust material from the reduced size, fiberized, fire-retarded cellulose material to remove from 15 wt % to 30 wt % of an overall weight of the reduced size, fiberized, fire-retarded cellulose material in the form of dust particles.
US Pat. No. 10,767,307

METHOD FOR CATALYTIC OXIDATION OF CELLULOSE AND METHOD FOR MAKING A CELLULOSE PRODUCT

UPM-KYMMENE, CORPORATION,...

1. A method for catalytic oxidation of cellulose using a heterocyclic nitroxyl radical as catalyst, main oxidant acting as oxygen source, and an activator of the heterocyclic nitroxyl radical, characterized in that the method comprises(a) a separate preliminary activation step of the heterocyclic nitroxyl radical consisting of activating the heterocyclic nitroxyl radical catalyst with hypochlorite in a reaction medium in the absence of cellulose and adjusting the pH with an acid to a pH of 6 to 8; and
(b) a cellulose oxidation step using the activated catalyst and main oxidant to oxidize primary hydroxyl groups of cellulose in a reaction medium comprising the activated heterocyclic nitroxyl catalyst, cellulose, and main oxidant at a pH higher than the pH of the preliminary activation step; and
wherein hypochlorite is used as the main oxidant in the cellulose oxidation step.
US Pat. No. 10,767,053

OXYGEN SCAVENGING POLYESTER COMPOSITIONS FOR CONTAINERS

APG Polytech, LLC, Wilmi...

1. An oxygen scavenging composition for containers comprising:at least one polyester component,
a transition metal catalyst,
an oxygen scavenger, and
a vegetable oil comprising at least one molecule having a double allylic structure,wherein the at least one polyester component comprises at least one acid unit and at least one diol unit, the concentration of the double allylic structures of the vegetable oil in the composition is greater than 14 meq/kg of all of the polyester components, the oxygen scavenger is present in the composition in a traditionally inert amount in the range of between 0.05% by weight and 0.9% by weight of the composition, and the vegetable oil is present in the composition at a level greater than 0.3% by weight relative to the total weight of the polyester components, the transition metal catalyst and the vegetable oil.
US Pat. No. 10,765,774

HEMOSTATIC PAD ASSEMBLY KIT AND METHOD

Ethicon, Inc., Somervill...

1. A method of making and using a hemostatic wound treatment device comprising: a bioabsorbable scaffold having a wound facing surface and an opposing surface; and a hemostatic powder that comprises a mixture of fibrinogen and thrombin, the method comprising:a) wetting the scaffold with the biocompatible liquid that is not blood or plasma selected from the group consisting of an aqueous solution, normal saline, ethanol, and ethanol-water mixture; then
b) contacting the scaffold with the hemostatic powder in dry form in a powder tray onto the wet scaffold and adhering at least a portion of the hemostatic powder to at least the wound facing surface of the scaffold; and then
c) applying the wound facing surface of the hemostatic wound treatment pad onto a wound.
US Pat. No. 10,766,030

METHOD AND APPARATUS FOR THE DETECTION OF BACTERIA

1. A method for the detection of bacteria comprising the steps ofA) provision of one or more suspensions each comprising at least one species of labelled test bacteriophages which specifically bind to a bacterial species to be detected;
B) addition of a sample to be tested for the presence of at least one bacterial species to be detected to the one or more suspensions;
C) filtration of the resulting reaction mixture, wherein a filter with a pore size of 0.1 ?m to 0.5 ?m is used;
D) detection of bacteria-bacteriophages-complexes in the retentate, provided that at least one bacterial species to be detected is present, wherein the complexes consist of bacteria of the at least one bacterial species to be detected and test bacteriophages of the at least one species of test bacteriophages bound thereto;
E) detection of unbound test bacteriophages in the filtrate;
F) processor-aided processing of received signals generated by the detection in steps D) and E) and output of detection results to a user,
wherein the one or more suspensions further comprise a labelled reference bacteriophage which does not bind to any bacterial species to be detected and which has a label disjunct from the test bacteriophages such that labelled reference bacteriophage is also detected in step E); or wherein labelled microparticles or nanoparticles are used in alternative to a labelled reference bacteriophage, which do not bind to any bacterial species to be detected and can pass through the filter due to their small size.
US Pat. No. 10,766,798

ENGINEERED YEAST AS A METHOD FOR BIOREMEDIATION

MASSACHUSETTS INSTITUTE O...

1. A composition for remediating a metal to treat water comprising:a cell; and
a first oligomer of a metal binding protein expressed on a surface of the cell via a linker;
wherein the linker is tethered to the first oligomer of the metal binding protein and to a surface of the cell;
wherein the metal binding protein has specificity for a metal; and
wherein the first oligomer of the metal binding protein expressed on the surface of the cell is capable of aggregating with a second oligomer of the metal binding protein in the water upon binding a metal, wherein the metal binding protein is fused with a high affinity protein including a metal binding domain, wherein the metal binding domain has specificity for the metal.
US Pat. No. 10,767,054

PROCESS FOR PREPARING INDIGO CARMINE

PROVEPHARM LIFE SOLUTIONS...

1. A process for preparing disodium 5,5?-indigosulfonate, the starting material being indigo, this process comprising the following steps:i) indigo is subjected to a sulfonation treatment leading to a mixture which contains 5,5?-indigosulfonic acid,
ii) the mixture obtained in step i) is subjected to a reduction treatment, and optionally a purification step, so as to obtain a composition comprising leuco-5,5?-indigosulfonic acid,
iii) the leuco-5,5?-indigosulfonic acid is isolated from the composition derived from step ii) and,
iv) the leuco-5,5?-indigosulfonic acid obtained from step iii) is oxidized to disodium 5,5?-indigosulfonate.
US Pat. No. 10,768,079

IN SITU HEAT INDUCED ANTIGEN RECOVERY AND STAINING APPARATUS AND METHOD

1. A microscope slide staining system, comprising:a chamber having an inner space;
a plurality of independently movable slide support elements positioned in the inner space of the chamber, each of the slide support elements configured to support a microscope slide;
a plurality of reagent packs with at least one reagent container on each of the reagent packs containing at least one reagent, the reagent packs being disk shaped and rotatably supported above the slide support elements such that the reagent contained in the reagent containers can be expelled from the reagent containers onto a respective one of the microscope slides when the microscope slide is positioned on the slide support element; and
a plurality of heating elements such that at least one of the heating elements is associated with one of the slide support elements to heat the at least one reagent on the microscope slide.
US Pat. No. 10,765,775

IMPLANTABLE MEDICAL DEVICES COMPRISING BIO-DEGRADABLE ALLOYS WITH ENHANCED DEGRADATION RATES

Bio DG, Inc., Poway, CA ...

1. A method of producing a biodegradable alloy that is austenitic in structure and includes iron, at least one additional metallic element, and an iron reactive component, wherein the iron reactive component is dispersed within the biodegradable alloy at a concentration between about 0.1 ppm to about 500 ppm, and wherein the degradation rate of the biodegradable alloy, when implanted in a biological subject, is greater than the degradation rate of an alloy having the same composition as the biodegradable alloy except the absence of the iron reactive component, the method comprising:melting iron, the at least one additional metallic element, and a salt containing the iron reactive component to produce a mixture; and
contacting the mixture with a gas containing the iron reactive component to produce the biodegradable alloy.
US Pat. No. 10,767,311

FIBROUS SUBSTRATE FOR PRODUCING A POROUS COATING BASE PAPER OR PREPREG, AND METHOD FOR THE PRODUCTION THEREOF

Schattdecor AG, Thansau ...

1. A fibrous substrate material for producing a porous coating base paper or prepreg, comprising:a planar impregnatable structure made of cellulose fibers, which contains at least one pigment species and which optionally contains further additives conventional for paper, wherein
the cellulose fibers contain a proportion of 1 to 20 wt.-% of nanofibrillated cellulose (NFC) with a specific surface (SSA) of at least 125 m2/g, wherein the fibrous substrate material is single-layered.
US Pat. No. 10,768,080

METHOD OF PURIFYING TUMOR CELLS USING SHEAR STRESS

University of Iowa Resear...

1. A method for purifying a fluid sample comprisingcontacting viable cancerous cells, viable normal cells and extracellular calcium with a micro fluidic device comprising:
(a) a conduit configured to contain the fluid sample; and
(b) a motorized pump operably coupled to the conduit, the motorized pump configured to pass the fluid sample through the conduit at a flow rate,
wherein the conduit and the motorized pump are configured to apply an initial pulse of fluid shear stress to the fluid sample in vitro, said initial pulse of fluid shear stress sufficient to induce a fluid shear stress resistance in the viable cancerous cells such that the magnitude of shear stress required to kill the viable cancerous cells is greater than the magnitude of shear stress required to kill the viable normal cells; and
wherein the conduit and the motorized pump are configured to subsequently apply one or more additional pulses of fluid shear stress to the fluid sample in vitro, said fluid shear stress sufficient to selectively kill the viable normal cells relative to the viable cancerous cells such that a ratio of the viable cancerous cells to the viable normal cells is increased;
applying an initial pulse of fluid shear stress to the fluid sample, wherein the initial pulse of fluid shear stress induces a fluid shear stress resistance in the viable cancerous cells such that the magnitude of shear stress required to kill the viable cancerous cells is greater than the magnitude of shear stress required to kill the viable normal cells; and
subsequently applying one or more additional pulses of fluid shear stress to the fluid sample comprising the fluid shear stress-resistant viable cancerous cells, said fluid shear stress sufficient to selectively kill the viable normal cells relative to the viable cancerous cells, whereby the ratio of viable cancerous cells to viable normal cells in the preparation is increased.
US Pat. No. 10,765,776

TISSUE-DERIVED BIOMATERIAL COMPOSITION AND METHODS FOR OCULAR AND OTHER THERAPEUTIC APPLICATIONS

SOUTH DAKOTA BOARD OF REG...

1. A method of preparing an extracellular matrix composition, comprising:extracting one or more corneas from one or more donor sources;
dissolving the one or more corneas in an aqueous solution of inorganic base to form a dissolved cornea solution;
dialyzing the dissolved cornea solution against at least one of a buffer solution or a serum-free medium to remove the inorganic base and adjust the pH of the dissolved cornea to physiological pH;
centrifuging the dissolved cornea solution; and
sterilizing the dissolved cornea solution.
US Pat. No. 10,767,056

COATING COMPOSITION INCLUDING A SALT HAVING A SILSESQUIOXANE ANION

LG CHEM, LTD., Seoul (KR...

1. A coating composition comprising:a radically polymerizable binder; and
a salt having a polysilsesquioxane anion containing at least two units represented by Formula 1 below and a radically polymerizable cation:
[RSiO3/2]  [Formula 1]
wherein R is a hydroxyl group, a thiol group, an oxygen anion (—O?) or a sulfur anion (—S?) and R in at least one unit of the at least two units of Formula 1 is an oxygen anion (—O?) or a sulfur anion (—S?).
US Pat. No. 10,767,312

METHOD FOR PRODUCING PAPER, BOARD OR THE LIKE

Kemira Oyj, Helsinski (F...

1. A method for producing paper or board, comprising:obtaining a thick stock comprising cellulose fibres;
forming a fibrous web; and
drying the fibrous web,
wherein
a strength agent system, comprising at least one synthetic or natural polymer or their mixture and a microfibrillated parenchymal cellulose material originating from non-wood sources is added to the thick stock, and
wherein a cationic retention polymer, which is a cationic polyacrylamide having an average molecular weight of 4,000,000-18,000 000 Da is added to the stock after the addition of the strength agent system.
US Pat. No. 10,767,057

COATING FILM, COMPOSITION FOR COATING FILM, FILM-FORMING AGENT, ARTICLE HAVING COATING FILM, AND METHOD FOR FORMING COATING FILM

DAIKIN INDUSTRIES, LTD., ...

1. A coating film comprising:(a) calcium carbonate having an average particle diameter of 600 nm to 9000 nm;
(b) a polyvinyl alcohol; and
(c) a copolymer comprising, as a constituent unit, a monomer having a perfluoroalkyl group of not more than 6 carbon atoms.
US Pat. No. 10,767,314

METHODS TO REDUCE REWINDER BREAKS DURING PAPER PRODUCTION FROM RECYCLED PAPER FURNISH

Epygen Labs FZ LLC, Duba...

1. A method to reduce sticky and fluff induced rewinder breaks in a paper rewinder machine by reducing the adhesive character of adhesive materials, fluff and sticky contaminants in recycled paper fibers for paper production, comprising:providing recycled paper fibers in aqueous solution as a pulp slurry; and
contacting the pulp slurry with a multi-enzyme composition for a sufficient time and in a sufficient amount to reduce the adhesive character of adhesive materials, fluff and sticky contaminants, wherein the multi-enzyme composition comprises:
21 to 24 wt % cellulase;
21 to 24 wt % hemicellulose;
13 to 16 wt % beta-glucosidase;
14 to 16 wt % lipase;
4 to 7 wt % pectate lyase;
7 to 8 wt % esterase; and
5 to 8 wt % laccase.
US Pat. No. 10,765,779

MEDICAL IMPLANT

THE UNIVERSITY OF SHEFFIE...

1. An acellular biomimetic medical device comprising a scaffold coated in or adsorbed on its surfaces with a first layer comprising a cationic agent, the first layer being covered or coated with a second layer comprising an anionic oligosaccharide or polysulphated moiety, which is non-covalently bound to a mixture of a plurality of bioactive factors, wherein the plurality of bioactive factors comprises:(i) an agent that can stimulate stem cell differentiation and/or promote appropriate extracellular matrix formation for the tissue to be regenerated selected from the transforming growth factor ? group; and
(ii) a stem cell homing or migratory factor which is a chemokines and optionally
(iii) an agent that inhibits enzymes associated with the breakdown or catabolism of extracellular matrix.
US Pat. No. 10,767,059

HIGH TEMPERATURE OXIDATION PROTECTION FOR COMPOSITES

GOODRICH CORPORATION, Ch...

1. A method for forming an oxidation protection system on a carbon-carbon composite structure, comprising:applying a first slurry onto a surface of the composite structure, wherein the first slurry is a sol gel comprising a metal organic salt comprising aluminum tri-sec butoxide, a first carrier fluid, ethanol, acetic acid, methanol, and a ceramic material;
heating the composite structure to a first sol gel temperature sufficient to form a sol gel-derived base layer on the composite structure;
forming a second slurry by combining a pre-slurry composition with a second carrier fluid, wherein the pre-slurry composition comprises a phosphate glass composition,
wherein the phosphate glass composition comprises at least one of phosphate glass or borophosphate glass;
applying the second slurry to the sol gel-derived base layer; and
heating the composite structure to a sealing temperature sufficient to form a sealing layer on the sol gel-derived base layer.
US Pat. No. 10,767,315

SYSTEM AND METHOD FOR MANUFACTURE OF PAPER, BOARD OR THE LIKE

Kemira Oyj, Helsinki (FI...

1. A drainage and a press dewatering system for manufacture of paper, board or the like, comprising:(a) an amphoteric polyacrylamide, which is a copolymer obtained by polymerizing (meth)acrylamide and 1-25 mol-% of cationic monomers and 0.1-24 mol-% of anionic monomers, the polyacrylamide having an intrinsic viscosity in a range of 6-38 dl/g determined in 1 M NaCl at 25° C.,
(b) inorganic microparticles of siliceous material, selected from colloidal silica or bentonite, and
(c) a high-charged cationic coagulant having a charge density over 5 meq/g determined at pH 6 and selected from aluminum based coagulants, organic polymers and mixtures thereof.
US Pat. No. 10,767,316

PAPER COMPRISING ARAMID PULP AND A FRICTION PAPER MADE THEREFROM

1. A paper comprising from 60 to 99 weight percent based on the total weight of the paper of an aramid fibrous pulp, said fibrous pulp comprising fibers, and from 1 to 40 weight percent based on the total weight of the paper of polyvinylpyrrolidone present as a coating on the surface of the fibers, the coating being neither chemically nor electrostatically bound to the fibers.
US Pat. No. 10,767,061

PLASTISOL BASED COMPOSITION FOR BLOCKING DYE MIGRATION FROM DYED POLYESTER FABRIC INTO THE PRINT

FUJIFILM SERICOL INDIA PV...

1. A plastisol based composition for use on a dyed polyester blended cotton fabric or 100% polyester fabric for blocking dye migration from said fabric into a print on the fabric, wherein said print is an overprint done with a plastisol based color dye on a layer of the dye blocking compound applied on said dyed fabric, said composition comprising:a. an acrylic based resin devoid of vinyl chloride moiety in an amount in the range of 15 to 45 wt % of the total weight of said composition;
b. a plasticizer in an amount in the range of 20 to 55 wt % of the total weight of said composition;
c. an organic wetting agent in an amount in the range of 5 to 35 wt % of the total weight of said composition;
d. a formaldehyde free discharge agent in an amount in the range of 2 to 30 wt % of the total weight of said composition; and
e. an extender in an amount in the range of 3 to 40 wt % of the total weight of said composition,
wherein said plastisol based composition is in the form of an ink and is devoid of water, formaldehyde, phthalate and vinyl chloride.
US Pat. No. 10,767,317

METHOD AND TREATMENT SYSTEM FOR MAKING OF PAPER

KEMIRA OYJ, Helsinki (FI...

1. A method for making of paper or surface ply of a multi-ply board from a fibre suspension, where at least 90 weight-% of fibres originate from chemical pulping process, chemi-thermo mechanical pulping process and/or office waste deinking pulping process, the fibre suspension further comprising inorganic mineral particles and cationic starch, said method comprising:incorporating a cationic copolymer of acrylamide and cationic monomers to the fibre suspension and allowing it to interact by flocculation with at least some of the components of the fibre suspension,
adding an anionic copolymer of acrylamide and more than 30 mol-% of anionic monomers to the fibre suspension,
forming the fibre suspension into a fibre web and drying the web to a dryness of at least 80%, and
applying an aqueous surface composition comprising a polymeric binder on a surface of the web.
US Pat. No. 10,768,342

ANTIREFLECTION FILM COMPRISING A LOW REFRACTIVE INDEX LAYER AND A HARD COATING LAYER

LG CHEM, LTD., Seoul (KR...

1. An antireflection film comprising: a low refractive index layer and a hard coating layer, wherein the low refractive index layer includes a binder resin containing a crosslinked polymer of a photopolymerizable compound and a polysilsesquioxane substituted with one or more reactive functional groups and inorganic fine particles dispersed in the binder resin;wherein a ratio of internal haze (Hi) to total haze (Ha) of the antireflection film is 97% or less, and
a variation in color coordinate value V) of the antireflection film before and after alkali treatment is 0.7 or less.
US Pat. No. 10,766,806

GLASS FOR DATA STORAGE MEDIUM SUBSTRATE, GLASS SUBSTRATE FOR DATA STORAGE MEDIUM, AND MAGNETIC DISK

AGC Inc., Chiyoda-ku (JP...

1. A glass comprising, in terms of mole percentage based on oxides:60% or more of SiO2,
more than 8.5% and less than 13% of Al2O3,
0 to 5% of MgO,
1 to 12% of CaO,
0 to 2% of SrO,
0 to 2% of BaO,
0 to 1% of TiO2,
0% or more and less than 4% of Li2O,
3 to 12% of Na2O,
0% or more and less than 4% of K2O,
0% or more and less than 0.01% of B2O3, and
0% or more and less than 0.01% of ZrO2,
wherein:
a total content (R2O) of Li2O, Na2O and K2O is 3 to 12%,
a total content of SiO2 and Al2O3 is 80.5% or less,
a molar ratio (SiO2/Al2O3) of the SiO2 content to the Al2O3 content is higher than 5,
a molar ratio [(SiO2+Al2O3)/R2O] of a total content (SiO2+Al2O3) of SiO2 and Al2O3 to R2O is higher than 9, and
contents of SiO2, Al2O3, RO and R2O are such that a value obtained by the Formula (1) is greater than 90:
[SiO2]+2×[Al2O3]+0.8×[RO]?0.5×[R2O]  Formula (1),
wherein in the Formula (1), RO represents a total content of MgO, CaO, SrO, and BaO.
US Pat. No. 10,767,065

NON-AQUEOUS INKJET INK COMPOSITION

SAKATA INX CORPORATION, ...

1. A non-aqueous inkjet ink composition comprising an acrylic resin, a pigment, a pigment dispersant, and an organic solvent, the non-aqueous inkjet ink composition characterized by comprising, as the organic solvent, a propylene carbonate and a diethylene glycol dialkyl ether, wherein:the acrylic resin contains acrylic resin (A) whose glass transition temperature is in a range of 90 to 110° C. and mass-averaged molecular weight is in a range of 20000 to 40000, and acrylic resin (B) whose glass transition temperature is in a range of 65 to 85° C. and mass-averaged molecular weight is in a range of 50000 to 80000, where a ratio of (A)/(B) is 70 to 90/10 to 30, and
the propylene carbonate is compounded by 5 to 25 percent by mass in the ink composition, and the diethylene glycol dialkyl ether is compounded in a manner providing a ratio of diethylene glycol dialkyl ether/propylene carbonate in a range of 3.0 to 8.0.
US Pat. No. 10,767,066

OIL-BASED INKJET INK

RISO KAGAKU CORPORATION, ...

1. An oil-based inkjet ink comprising a colorant and a non-aqueous solvent, wherein the non-aqueous solvent contains at least 15% by mass but not more than 100% by mass, relative to a total mass of the non-aqueous solvent, of an organosilicon compound having 2 to 6 silicon atoms in one molecule, having an organic group in which a carbon atom is bonded directly to a silicon atom and in which a total number of carbon atoms and oxygen atoms is at least 4, and having a total number of carbon atoms and oxygen atoms, contained within all of the organic groups in which the total number of carbon atoms and oxygen atoms is at least 4, that is from 4 to 20 within one molecule.
US Pat. No. 10,767,067

NON-AQUEOUS INKJET INK COMPOSITION

SAKATA INX CORPORATION, ...

1. A non-aqueous inkjet ink composition containing an acrylic resin, a ketone resin, a pigment, and a pigment dispersant, and also containing propylene carbonate and diethylene glycol dialkyl ether as an organic solvent, wherein, in the ink composition,the propylene carbonate is contained by 5 to 25 percent by mass, and
the diethylene glycol dialkyl ether is contained at a ratio of the diethylene glycol dialkyl ether to the propylene carbonate by mass, which ratio is 3.0 to 8.0,
wherein the acrylic resin and the ketone resin are contained at an acrylic resin/ketone resin ratio by mass of 3.0 to 20.0.
US Pat. No. 10,766,812

COMPOSITION CONTAINING MODIFIED CHROMATE-DEFICIENT RED MUD AND METHOD FOR PRODUCING SAME

Fluorchemie GmbH Frankfur...

1. A composition comprising modified, chromate-deficient red mud with a mineral composition of:10 to 50% by weight of iron compounds;
12 to 35% by weight of aluminium compounds;
5 to 17% by weight of silicon compounds;
2 to 10% by weight of titanium dioxide;
0.5 to 6% by weight of calcium compounds; and
0 to 1 ppm of chromium (VI) compounds;
wherein the modified, chromate-deficient red mud comprises a poorly soluble reducing agent for Cr(VI);
wherein the composition further comprises a pH buffer system which is configured for stabilising a pH range in which the poorly soluble reducing agent for Cr(VI) and a resulting Cr(III) have a solubility in water at 25° C. of less than 1 g/l; and
wherein the composition further comprises at least one of:
an agent for removing nitrate and nitrite which is selected from the group consisting of urea and amidosulfonic acid; and
an agent which is configured for removing pollutants by means of the formation of poorly soluble salts.
US Pat. No. 10,767,068

PHOTOCURABLE INKJET PRINTING INK COMPOSITION

SAKATA INX CORPORATION, ...

1. A photocurable inkjet printing ink composition containing a photopolymerizable compound and a photopolymerization initiator, wherein in 100 percent by mass of the photocurable inkjet printing ink composition, included are:a. an acrylamide-based monomer by 22.0 to 50 percent by mass, which is expressed by General Formula (I) below:
CH2?CR4-CON(R5)R6
wherein R4 represents a hydrogen atom or a methyl group; R5 and R6 may be the same or different, and although they are each a hydrogen atom or a substituted or an unsubstituted alkyl group with the carbon number from 1 to 8, they are not a hydrogen atom at the same time; and alternatively, R5 and R6 may be bonded to form a ring together with an adjacent nitrogen atom;
b. a monofunctional monomer other than acrylamide-based monomer by 15 to 70 percent by mass;
c. a polymerizable compound having two or more functionalities by 5.0 to 20.0 percent by mass;
d. an acrylated amine compound having two photopolymerizable functional groups and two amino groups in the molecule by more than 0 percent by mass but no more than 10 percent by mass; and
e. the percentage of monofunctional monomers in the photopolymerizable compound is 60 to 99.5 percent by mass.
US Pat. No. 10,766,813

NANOCELLULOSE FOAM STABILIZING ADDITIVE

Halliburton Energy Servic...

1. A method of cementing comprising:providing a foamed cement composition comprising:
a hydraulic cement,
water,
a foaming surfactant,
a gas, and
a nanocellulose foam stabilizing additive;
placing the foamed cement composition in a selected location; and
allowing the foamed cement composition to set,
wherein the nanocellulose foam stabilizing additive comprises a nanofibril cellulose.
US Pat. No. 10,767,069

AQUEOUS CARBON NANOPARTICLE INK COMPOSITION FOR RESISTORS

XEROX CORPORATION, Norwa...

1. An aqueous ink composition comprising an aqueous solvent, one or more carbon nanoparticles, and one or more cellulose nanocrystals, wherein the one or more carbon nanoparticles comprise non-functionalized multi-walled nanotubes, wherein the aqueous ink composition has a viscosity at 25° C. of from about 1 cP to about 15 cP, wherein the one or more cellulose nanocrystals comprise primary alcohol groups, and wherein the primary alcohol groups of the cellulose nanocrystals are oxidized to respective carboxylate groups.
US Pat. No. 10,767,070

PROCESS FOR PREPARING MULTI-COLOR DISPERSIONS AND MULTI-COLOR DISPERSIONS MADE THEREOF

Dow Global Technologies L...

1. A process for making a multi-color dispersion comprising:i) contacting together
a first colorant,
a first aqueous dispersion of polymer particles comprising a polymerized product of at least one ethylenically unsaturated nonionic monomer comprising (meth)acrylic esters,
two or more of a first polysaccharide selected from the group consisting of guar, pectin, and carrageenan, and
two or more of a second polysaccharide selected from the group consisting of gelatin, methyl cellulose, and hydroxpropyl methyl cellulose to make a first colorant dispersion;
wherein the first colorant dispersion comprises from 0.1 wt. % to 5 wt. % of the first colorant, from 1 wt. % to 60 wt. % of the first aqueous dispersion of polymer particles, and from 0.1 wt. % to 10 wt. % each independently of the first and second polysaccharide;
ii) contacting the first colorant dispersion with a composition comprising
a) a second aqueous dispersion of polymer particles comprising a polymerized product of at least one ethylenically unsaturated nonionic monomer and
b) an ionic complexing agent to obtain a dispersion of protected first colorant particles;
wherein the composition comprises from 0.5 wt. % to 75 wt. % of the second aqueous dispersion of polymer particles, and from 0.1 wt. % to 5 wt. % of the ionic complexing agent, and wherein the ionic complexing agent comprises a phosphate, a hydrogen phosphate, a sulfate, borate, a citrate, or a chloride salt of Mg2+, Ca2+, Zn2+, or Ti4+, sodium borate, or boric acid;
iii) repeating steps i) and ii) with a second colorant that is different from the first colorant to obtain a dispersion of protected second colorant particles; and
iv) mixing the dispersions of protected first and second colorant particles to obtain a multi-color dispersion;
wherein the weight: weight ratio of the first polysaccharide to the second polysaccharide is from 1:3 to 3:1; and
wherein all weight percents are based on the total weight of the multi-color dispersion.
US Pat. No. 10,766,815

ENGINEERED STONE AND MANUFACTURING METHOD THEREOF

Lotte Advanced Materials ...

1. An engineered stone, comprisinga light transmitting mother material (I) and a phosphorescent chip (II),
wherein the light transmitting mother material (I) includes about 7 wt % to about 12 wt % of an unsaturated polyester resin (A) and about 88 wt % to about 93 wt % of a silica-containing compound (B) based on a total amount of the unsaturated polyester resin (A) and the silica-containing compound (B) of the light transmitting mother material (I),
the light transmitting mother material (I) further includes about 0.01 part by weight to about 1 part by weight of an organic/inorganic pigment (C) based on about 100 parts by weight of the unsaturated polyester resin (A),
the phosphorescent chip (II) includes about 8 wt % to about 15 wt % of an unsaturated polyester resin (A?) and about 85 wt % to about 92 wt % of a silica-containing compound (B?) based on a total amount of the unsaturated polyester resin (A?) and the silica-containing compound (B?) of the phosphorescent chip (II),
the phosphorescent chip (II) further includes 2 parts by weight to 5 parts by weight of a phosphorescent pigment (D) based on 100 parts by weight of the unsaturated polyester resin (A?), and
the silica-containing compound (B?) includes about 20 wt % to about 30 wt % of a silica powder (b1?) based on a total amount of the phosphorescent chip (II).
US Pat. No. 10,766,816

BUILDING COMPOSITION MARKER

NOURYON CHEMICALS INTERNA...

1. A method for determining the origin of a building composition, the method comprising:including a building composition marker in the building composition, wherein the building composition marker comprises at least one alpha-amino acid, alpha-amino acid salt or a mixture thereof as a marker for determining the origin of a building composition; and
adding a test composition to the building composition and reacting the test composition with the building composition marker to cause a visibly detectable color change.
US Pat. No. 10,767,072

POLYMER, PROCESS AND USE

DSM IP ASSETS B.V., Heer...

1. A process for preparing an aqueous binder composition free of organic solvent, the process comprising at least the following steps:A) preparing a hydrophilic vinyl polymer (Polymer A) having an acid value (AV) from 32 to 98 mg KOH/g of solid Polymer A by polymerizing a monomer composition A that comprises:
Ai) at least one carboxylic acid functional olefinically unsaturated monomer;
Aii) at least one olefinically unsaturated monomer different than monomer Ai); and
Aiii) optionally at least one wet adhesion promoting olefinically unsaturated monomer different than monomers Ai) and Aii); and
B) preparing a hydrophobic vinyl polymer (Polymer B) having an acid value (AV) of no more than 23.4 mg KOH/g of solid Polymer B by emulsion polymerization of a monomer composition B in the presence of the Polymer A, wherein the monomer composition B comprises:
Bi) at least one olefinically unsaturated monomer;
Bii) optionally a carboxylic acid functional olefinically unsaturated monomer different than monomer Bi); and
Biii) optionally a wet adhesion promoting olefinically unsaturated monomer different than monomer Bi); wherein
at least a part of the carboxylic acid groups that are present in Polymer A and Polymer B are neutralized during or following the step A and/or during the step B to form at least a partially neutralized polymer emulsion; wherein
the Polymer A has a weight average molecular weight (Mw) that is lower than a weight average molecular weight (Mw) of the Polymer B; and
the process further comprises the step of:
C) reacting at least 10 mol % of the carboxylic acid and/or carboxylate salt groups of the at least partially neutralized polymer emulsion with an iminating agent to produce an iminated Polymer C; wherein
surfactant in steps A), B) and C) is present in a total amount of at most 0.5 wt. %, based on total weight of monomers present for preparing the Polymers A and B.
US Pat. No. 10,766,305

PNEUMATIC TIRE

SUMITOMO RUBBER INDUSTRIE...

17. A pneumatic tire, comprising a tread formed from a rubber composition,the rubber composition including a quinoline antioxidant and a p-phenylenediamine antioxidant, and
the rubber composition having after vulcanization rubber properties satisfying all the following relations (1) to (7):
(tan ?1/tan ?2)?4.38  (1)
(E*/tan ?2)?21.88  (2)
3.5?E*?6.0  (3)
tan ?2?0.16  (4)
tan ?1?0.70  (5)
EB?600  (6)
TB×EB?12000  (7)where tan ?1 in relations (1) and (5) represents a tan ? at 0° C. determined by viscoelastic measurement at an initial strain of 10% and a dynamic strain of 5%; tan ?2 in relations (1), (2), and (4) represents a tan ? at 30° C. determined by viscoelastic measurement at an initial strain of 10% and a dynamic strain of 2%; E* in relations (2) and (3) represents a dynamic elastic modulus (E* (MPa)) at 30° C. determined by viscoelastic measurement at an initial strain of 10% and a dynamic strain of 2%; EB in relations (6) and (7) represents a tensile elongation (EB (%)) determined in accordance with JIS K 6251; and TB in relation (7) represents a tensile strength at break (TB (MPa)) determined in accordance with JIS K 6251.
US Pat. No. 10,766,817

CHEMICAL SUBSTITUTIONS FOR PORTLAND CEMENT MIXTURES AND APPLICATIONS THEREFOR

Surface Tech LLC., La Jo...

1. A dry cementitious mixture comprising:stone, sand, Portland cement, fly ash and mineral fibers mixed together to produce a dry cementitious mixture having roughly uniform ingredient distribution and a total weight, wherein
a weight of the stone is between 40 and 50% of the total weight;
a weight of the sand is between 30 and 40% of the total weight;
a weight of the Portland cement is between 10 and 15% of the total weight;
a weight of the fly ash is between 5 and 10% of the total weight; and
a weight of the mineral fibers is between 0.5 and 2% of the total weight, the mixture further comprising:
wollastonite as a portion of the fly-ash component, a weight of the wollastonite being between 1% and 7.5% of the total weight, and wherein
said wollastonite made up of at least one grade of powder wollastonite and at least one grade of anisotropic wollastonite particles.
US Pat. No. 10,766,818

SUPPLEMENTARY CEMENTITIOUS MATERIAL MADE OF ALUMINIUM SILICATE AND DOLOMITE

HConnect 2 GmbH, Heidelb...

1. A method for producing a latent hydraulic and/or pozzolanic supplementary cementitious material, including adjustment of the colour thereof, comprising the steps:Provision of a starting material containing an aluminium silicate constituent and a dolomite constituent and having a ratio (SiO2+Al2O3)/(CaO+MgO) from 0.7 to 6,
Conversion of the starting material to the supplementary cementitious material by burning the starting material under reducing conditions in the temperature range of >700° C. to 1100° C. if no mineralisers are contained, and in the temperature range of 625° C. to 950° C. if mineralisers are contained.
US Pat. No. 10,767,074

PROCESS FOR THE MANUFACTURE OF A CROSSLINKABLE COMPOSITION

Allnex Netherlands B.V., ...

1. A process for the preparation of a RMA crosslinkable composition comprising at least one crosslinkable component comprising reactive components A and B each comprising at least 2 reactive groups wherein the at least 2 reactive groups of component A are acidic protons C—H in activated methylene or methine groups and the at least 2 reactive groups of component B are activated unsaturated groups C?C and base catalyst C and one or more N—H group containing reactivity moderating component D that are also a Michael addition donor reactable with component B under the action of catalyst C, characterized in that the one or more reactivity moderating components D have a melting temperature above 60° C. and is first dissolved in one or more crosslinkable components comprising reactive components A or B and the obtained pre-dissolved product is later mixed with other components of the RMA crosslinkable composition and wherein component D is dissolved in the one or more crosslinkable component comprising reactive components A or B at a temperature above its melting temperature.
US Pat. No. 10,768,099

IN-VITRO BIOLOGICAL VALVE CALCIFICATION EVALUATION METHOD AND REDUCING CALCIUM INGREDIENT SOLUTION

VENUS MEDTECH (HANGZHOU) ...

1. An in-vitro biological valve calcification evaluation method, comprising the steps of:(1) preparing calcification evaluation solutions, the calcification evaluation solutions comprising: glutaraldehyde solution, saline solution, borate buffer solution, reducing calcium ingredient solution and calcium-containing plasma solution, wherein the reducing calcium ingredient solution comprises an alcohol, an alkaline solution, an oil and/or its derivatives, and a buffer solution;
(2) preheating the reducing calcium ingredient solution by placing the reducing calcium ingredient solution in a 30 to 40° C. thermostat water bath;
(3) conducting treatment prior to reducing calcium ingredient solution by taking a biological valve sample and soaking the biological valve sample in the glutaraldehyde solution completely, and maintaining the biological valve sample at room temperature;
(4) conducting treatment with the reducing calcium ingredient solution by removing the glutaraldehyde solution, and adding the borate buffer solution, immersing the sample therein, then removing the borate buffer solution, and soaking the sample in the reducing calcium ingredient solution completely within a 30 to 40° C. thermostat water bath;
(5) preserving the biological valve samples by removing the reducing calcium ingredient solution from a container and adding the saline solution until the biological valve sample is completely soaked, and storing the sample in the container;
(6) conducting an in-vitro calcification reaction by putting the biological valve sample into the calcium-containing plasma solution in a 30 to 40° C. thermostat water bath for a period of any days within 60 days to let the biological valve sample fully react with the given calcium ions of the solution, such that calcium ions are bonded to the biological valve sample by chemical bonding ;
(7) detecting calcium content measuring the calcium content of the biological reacted valve sample by atomic absorption spectrometry to evaluate the calcium content of the biological valve sample, and comparing it with a standard sample.
US Pat. No. 10,765,538

BIODEGRADABLE SUPPORTING DEVICE

Q3 MEDICAL DEVICES LIMITE...

1. An in vivo supporting device, comprising:a biodegradable metal scaffold; and
a biodegradable polymer coating covering at least a portion of said biodegradable metal scaffold,
wherein said biodegradable polymer coating has a thickness of 10-200 ?m and a degradation rate that is different than the degradation rate of said biodegradable metal scaffold,
wherein said biodegradable metal scaffold comprises an alloy,
wherein the alloy comprises magnesium, manganese, and at least one rare earth metal,
wherein the biodegradable metal scaffold comprises metal struts,
wherein the biodegradable polymer coating partially covers the metal struts, but does not cover openings between the struts, and
wherein the struts from the biodegradable metal scaffold are fully encapsulated by the biodegradable polymer coating and the coated struts and openings therebetween are fully covered by the biodegradable polymer covering.
US Pat. No. 10,766,819

COMPOSITIONS AND METHODS FOR CONTROLING SETTING OF CARBONATABLE CALCIUM SILICATE CEMENTS CONTAINING HYDRATING MATERIALS

SOLIDIA TECHNOLOGIES, LTD...

1. A method for suppressing premature setting of a carbonateable calcium silicate composition comprising one or more hydraulic contaminants, comprising adding one or more set-retarding or hydration-controlling compounds or admixtures to a carbonateable calcium silicate composition or a precursor composition thereof.
US Pat. No. 10,767,075

COATING COMPOSITION COMPRISING NANO-SOL, AND PREPARATION METHOD THEREOF

Nanoshield Technology Co....

1. A coating composition, comprising:a curable polymer comprising at least one functional group for forming cross-linking structures;
a curative configured to react with the at least one functional group in the curable polymer, wherein the curable polymer is a vinyl or acrylic modified alkyd resin;
a sol comprising silica or metal oxide nanoparticles having a particle diameter in a range of from about 0.1 nm to about 100 nm;
an organic titanate; and
optionally at least one solvent or diluent.
US Pat. No. 10,767,076

WATER-REDUCIBLE COATING COMPOSITION

SWIMC LLC, Cleveland, OH...

1. A coated article, comprising;at least a portion of an exposed surface of a metal substrate; and
a coating system applied to at least the exposed surface, wherein the coating system comprises:
a water-reducible alkyd resin comprising the reaction product of
about 65 to 75 wt % of a polyester feedstock comprising
about 20 to 80% by weight of polyethylene terephthalate;
about 1 to 10% by weight of a hydroxyl-functional compound; and
about 1 to 20% by weight of a carboxyl-functional compound, based on the total weight of the polyester feedstock; and
about 25 to 35 wt % of a waste cooking oil feedstock comprising yellow grease, brown grease, or mixtures thereof.
US Pat. No. 10,766,821

INORGANIC-ORGANIC PHOSPHATE CERAMICS AND COATINGS

Latitude 18, Inc., Sims,...

1. A sprayable inorganic-organic phosphate ceramic precursor system comprising:an aqueous-based slurry or a suspension, separately comprising components (a) and (b) as follows:
(a) at least one inorganic phosphate of formula (i), Am(H2PO4)m.nH2O or (ii) AH3(PO4)2.nH2O; where A is an m-valent metal element; m=1, 2, or 3; and n is 0 to 25; and
(b) at least one basic oxide or hydroxide of formula B2mOm or B(OH)2m, where B is a 2m-valent metal; and m=1 or 1.5; and
at least one organic phase precursor present at a weight percent of 2 to 50 in (a) or (b), or (a) and (b), wherein the at least one organic phase precursor is the product of a reaction with the at least one inorganic phosphate or the at least one basic oxide or hydroxide.
US Pat. No. 10,767,078

WATER-BASED PAINT COMPOSITION FOR VEHICLE

KCC Corporation, Seoul (...

1. A water-based paint composition for a vehicle, the water-based paint composition comprising:a core-shell microgel resin, a dimer-modified polyester resin, a (meth)acryl-modified polyurethane resin, a curing agent, a pigment, and water,
wherein the dimer-modified polyester resin is comprised in an amount of 1 to 10 wt % with respect to 100 wt % of the water-based paint composition.
US Pat. No. 10,767,080

1K WATERBORNE DRY-ERASE COATING COMPOSITION

The Sherwin-Williams Comp...

1. A method of making a coating composition, the method comprising:reacting an excess amount of an aminosilane with an epoxy alcohol in aqueous media to yield a silylamino polyol crosslinker; and
including an epoxysilane in the reaction and allowing the epoxysilane to react with the aminosilane to yield an aminodisilane crosslinker, wherein a coating composition is formed that includes the silylamino polyol crosslinker and the aminodisilane crosslinker.
US Pat. No. 10,766,825

SELF-DISPERSIBLE MIXTURE SILICON ADDITIVE COMPOSITION, ITS EMULSION AND ITS USE THEREOF

WACKER METROARK CHEMICALS...

1. A composition comprising:a self-dispersible mixture additive composition comprising:
50 to 90 weight percent, based on the total weight of the composition, of a hydrolysate of alkylalkoxysilane
i. (RO)4-nSiR?n  (I)
where, n is any number from 1 to 3,
R is same or different and is a C1-C20 group,
R? is same or different and is a C1-C20 group; and
50 to 10 weight percent, based on the total weight of the composition, of one or more non-ionic emulsifiers having an HLB value between 8 and 20, wherein, the one or more non-ionic emulsifiers are selected from polyoxyalkylene alkyl ether, polyoxyalkylene alkyl phenyl ethers and polyoxyalkylene sorbitan esters.
US Pat. No. 10,766,827

PELLETIZED BASALT FOR USE AS A SOIL AMENDMENT

Specialty Granules Invest...

1. A soil amendment composition comprising:at least one of basalt, metabasalt, or a combination thereof, wherein the at least one of basalt, metabasalt, or a combination thereof is present at 50 wt % to 98 wt % based on a total weight of the soil amendment composition; and
a binding agent,
wherein the binding agent is present at 1 wt % to 20 wt % based on the total weight of the soil amendment composition,
wherein the binding agent is humic acid,
wherein the soil amendment composition is in the form of a plurality of particles, and
wherein the plurality of particles have an average particle size of about 0.25 mm to about 10 mm.
US Pat. No. 10,767,083

POLYOLEFIN HOT-MELT GLUE HAVING A LOW REACTIVATION TEMPERATURE AND HIGH HEAT STABILITY AND USE THEREOF FOR VACUUM DEEP-DRAWING LAMINATION

SIKA TECHNOLOGY AG, Baar...

1. A method for producing a bonded assembly composed of a substrate element and a foil by adhesive bonding, the method comprising the following steps:a) applying a hotmelt adhesive composition to one side of a foil, wherein the hotmelt adhesive composition comprises
1) at least one atactic poly-?-olefin (APAO) which is solid at 25° C.;
2) at least one hydrocarbon resin having a softening point of at least 80° C., measured by the ring & ball method according to DIN EN 1238; and
3) at least one maleic anhydride-grafted wax having a softening point of not more than 150° C., measured by the ring & ball method according to DIN EN 1238, which is a maleic anhydride-grafted polypropylene wax or a maleic anhydride-grafted polyethylene wax,
wherein a fraction of the at least one maleic anhydride-grafted wax in the hotmelt adhesive composition is at least 3 wt %,
wherein the hotmelt adhesive composition contains no atactic poly-?-olefin containing silane groups, and
wherein a fraction of further thermoplastic polymers which differ from 1) the atactic poly-?-olefin (APAO), 2) the hydrocarbon resin, and 3) the maleic anhydride-grafted wax in the hotmelt adhesive composition is less than 5 wt % of the hotmelt adhesive composition;
b) heating the foil coated with the hotmelt adhesive composition, for reactivating, and
c) drawing the reactivated foil, coated with the hotmelt adhesive composition, onto the substrate element, with the hotmelt adhesive composition coming into contact with the substrate element and, after cooling, producing the bonded assembly.
US Pat. No. 10,766,830

COMPOSITIONS WITH SOLID FUEL LOADED ON GRAPHENE FOAMS

Purdue Research Foundatio...

1. A composition comprising a graphene foam and a solid fuel, wherein the graphene foam has an average porosity of 50.0-99.99%.
US Pat. No. 10,767,087

ADHESIVE COMPOSITION

BOREALIS AG, Vienna (US)...

16. The pipe according to claim 1, wherein the adhesive layer is coated with at least one surface layer comprising a polyethylene composition.
US Pat. No. 10,766,833

HYDROFORMYLATION METHOD AND CATALYST USING RHODIUM-RUTHENIUM DUAL METAL AND TETRADENTATE PHOSPHINE LIGAND

Wuhan Catalys Technology ...

1. A catalyst comprising a rhodium complex and a ruthenium compound, wherein the rhodium complex is formed by complexing a rhodium compound with a biphenyl tetraphosphine ligand, and the ruthenium compound does not complex with the biphenyl tetraphosphine ligand, the rhodium compound and the rhodium complex.
US Pat. No. 10,766,834

TRANSALKYLATION PROCESSES AND CATALYST COMPOSITIONS USED THEREIN

ExxonMobil Chemical Paten...

1. A process for producing ethylbenzene comprising:(a) providing a selectivated transalkylation catalyst composition;
(b) providing a stream comprising poly-alkylated benzene and a stream comprising benzene, wherein said stream comprising poly-alkylated benzene comprises di-ethylbenzene; and
(c) contacting said stream comprising poly-alkylated benzene with said stream comprising benzene in presence of the selectivated transalkylation catalyst composition under at leas partially liquid phase transalkylation conditions to produce a transalkylation effluen stream comprising said ethylbenzene,
wherein a method for making said selectivated transalkylation catalyst composition comprises:
(i) contacting an untreated transalkylation catalyst composition with a selectivating solution to form said selectivated transalkylation catalyst, said transalkylation catalyst composition comprising a zeolite in acid form and having an MWW framework structure, said selectivating solution comprises water and a cation or an anion of an element in Group 1, Group 2, or Group 17 of the Periodic Table, wherein said selectivated transalkylation catalyst composition has a higher selectivity to ethylbenzene than the selectivity of said transalkylation catalyst composition that has not been contacted with said selectivating solution when the catalysts are compared under equivalent transalkylation conditions,
wherein said element in Group 1 is sodium or potassium, said element in Group 2 is calcium, and said element in Group 17 is chlorine,
wherein said selectivating solution comprises dissolved ions which include one or more of the following elements: calcium in an amount from 600 to 750 milligrams per liter (mg/L), sodium in an amount from 400 to 500 mg/L, potassium in an amount from 40 to 80 mg/L, and chlorine in an amount from 650 to 850 mg/L,
wherein step (i) comprises contacting said untreated transalkylation catalyst composition with said selectivating solution for 1 hour or more at a temperature in a range of 20° C. to 95° C. and at a pH of the selectivating solution in a range of 6.5 to 8.0.
US Pat. No. 10,767,092

TETRAFLUOROPROPENE COMPOSITIONS AND USES THEREOF

THE CHEMOURS COMPANY FC, ...

1. A composition comprising a refrigerant consisting of from about 20 weight percent to about 80 weight percent HFO-1234yf, about 5 weight percent to about 40 weight percent HFC-134a, and about 5 weight percent to about 40 weight percent HFC-152a.
US Pat. No. 10,766,838

PROCESS FOR PRODUCING HIGHLY PURE CHLORINATED ALKANE

SPOLEK PRO CHEMICKOU A HU...

1. A method of synthesizing a fluorinated alkane, fluorinated alkene, chlorinated alkene, or chlorofluorinated alkene, comprising providing a feedstock of a highly pure chlorinated alkane composition comprising 1,1,1,2,3-pentachloropropane in amounts of at least about 99.8 wt % and oxygenated organic compounds in amounts of about 5 ppm to about 100 ppm.
US Pat. No. 10,770,169

METHOD OF PROVIDING A TREATMENT TO A SUBJECT BASED ON A DYNAMIC PATHWAY MAP

THE REGENTS OF THE UNIVER...

1. A method of generating a dynamic pathway map (DPM), comprising:accessing a pathway element database storing at least one pathway including a plurality of pathway elements comprising genes, RNA, and proteins;
associating a first pathway element of the pathway element database with at least one known attribute corresponding to a gene, an RNA, or a protein by connecting the first pathway element to the at least one known attribute using at least one edge in a factor graph;
associating a second pathway element of the pathway element database with at least one assumed attribute corresponding to a gene, an RNA, or a protein by connecting the second pathway element to the at least one assumed attribute using at least one edge in the factor graph;
cross-correlating the first pathway element, the second pathway element, and additional pathway elements for the at least one pathway using the edges in the factor graph;
assigning, based on the cross-correlating, an influence level of the first and second pathway elements relative to activity or expression of each other or the additional pathway elements for the at least one pathway using the at least one known attribute and the at least one assumed attribute, wherein the influence level corresponds to an edge of the factor graph;
converting each pathway of the at least one pathway, and the influence level of the first and second pathway elements for the at least one pathway, to a probabilistic pathway model having each interaction in each pathway represented as an edge in the factor graph of the probabilistic pathway model, with the influence level of the first and second pathway elements comprising one of a negative value or a positive value, the negative value and the positive value correlated to the corresponding edge of the factor graph associated with the at least one pathway;
storing the probabilistic pathway model, additional pathway models, and a plurality of measured attributes for a plurality of elements based on a genome-scale assay of a biological sample, each instance model having edges between pathway elements comprising genes, RNA, and proteins, with the edges having influence levels;
deriving the DPM from expectation maximization of the probabilistic pathway model and the plurality of measured attributes for the plurality of elements based on the genome-scale assay of the biological sample, as well as the additional pathway models, to determine influence levels across the pathway models, the DPM inferring probabilistic reference pathway activity information for pathway elements of a particular pathway; and
identifying that an activity or an expression of a particular pathway element of the particular pathway is altered for the biological sample compared to a control based on pathway inferences in the DPM, wherein at least one method operation is executed by a processor, and wherein the biological sample was obtained from a subject; and
providing a treatment to the subject based on the activity or the expression of the pathway element of the particular pathway being altered compared to the control, wherein the treatment is administration of a pharmaceutical.
US Pat. No. 10,766,841

METHOD OF PREPARING BIO-POLYOLS FROM EPOXIDIZED FATTY ACID ESTERS

CPC Corporation, Kaohsiu...

1. A method of preparing bio-polyols from epoxidized fatty acid esters comprising steps of:replacing amphoteric compound by using alkyl sulfonic acid, wherein the alkyl sulfonic acid are synthesized with Brønsted strong acid to produce Brønsted acid IL, a molar ratio of the alkyl sulfonic acid and the Brønsted strong acid is within 1.0 to 1.5;
mixing the epoxidized fatty acid esters and the Brønsted acid IL at a predetermined ratio, adding alcohols for using as ring-opening reagent, thus producing reaction solution, wherein the reaction solution is heated within a temperature of 30° C. to 100° C. for 1 to 24 hours to cause ring-opening hydroxylation, wherein a molar ratio of the alcohols and the epoxidized fatty acid esters is within 4 to 20, and a molar ratio of the Brønsted acid IL and the epoxidized fatty acid esters is within 0.01 to 0.15; and
extracting and layering the reaction solution by using deionized water to acquire upper-layer solution and lower-layer solution, wherein the lower-layer solution consists of ionic liquid which is concentrated and dried to recycle reusable ionic liquid, and the upper-layer solution consists of bio-polyols which are extracted by using the deionized water and alkaline water and then dehydrated.
US Pat. No. 10,766,842

ANHYDROSUGAR ALCOHOL COMPOSITION HAVING ENHANCED STORAGE STABILITY, AND ANHYDROSUGAR ALCOHOL STORAGE METHOD

SAMYANG CORPORATION, Seo...

1. A composition comprisinga concentrated anhydrosugar alcohol; and
an amine compound as an additive for stabilization;
wherein the concentrated anhydrosugar alcohol is dianhydrohexitol in solid form,
wherein the amine compound is selected from the group consisting of piperidine, 1,8-diazabicycloundec-7-ene, 1,5-diazabicyclo[4.3.0]non-5-ene and combinations thereof, each of which is unsubstituted or substituted with one or more substituents selected from the group consisting of linear or branched C1-C10alkyl, C3-C10cycloalkyl, aminoC1-C10alkyl, mono- or di-C1-C10alkylaminoC1-C10alkyl, carboxamide and amino, and
wherein an amount of the amine compound is 1 ppm or more and 300 ppm or less, based on a weight of the concentrated anhydrosugar alcohol.
US Pat. No. 10,767,098

METHOD OF USING SIZED PARTICULATES AS SPACER FLUID

Baker Hughes, a GE compan...

1. A method of separating an aqueous cement slurry from a drilling mud during a cementing operation in a wellbore, the method comprising:(a) introducing into the wellbore a spacer fluid comprising particulates of a hydratable polymeric viscosifying agent having a particle size distribution such that a minimum of 90% of the particulates are retained on a 20 mesh screen, wherein the spacer fluid is introduced into the wellbore after introducing the drilling mud into the wellbore and before introducing the aqueous cement slurry into the wellbore and wherein the spacer fluid prevents contact between the drilling mud and the cement slurry;
(b) displacing at least a portion of the drilling mud from the wellbore and emplacing the cement slurry in the displaced area; and
(c) curing the cement slurry wherein the temperature within the bottom hole temperature of the wellbore is 300° F. or higher.
US Pat. No. 10,766,844

AROMATIC COMPOUNDS BEARING HYDROXYL-SUBSTITUTED (PER)FLUOROPOLYETHER CHAINS

SOLVAY SPECIALTY POLYMERS...

1. A compound (L) comprising at least one moiety (A*) wherein moiety (A*) is selected from benzene, biphenyl and naphthalene, and wherein:at least two carbon atoms of moiety (A*) are substituted with a fluoropolyoxyalkene chain (Rf), each chain (Rf) comprising:
a) a fluorocarbon segment having ether linkages in the main chain and
b) at least one hydroxyl group,each chain (Rf) being bound to an sp2 carbon atom of said moiety (A*) through bridging group (B) comprising at least one heteroatom directly bound to said sp2 carbon atom, and wherein:in moiety (A*), all carbon atoms which do not bear a chain (Rf) are substituted with a fluorine atom.
US Pat. No. 10,767,101

METHODS OF CONTROLLING FINES MIGRATION IN A WELL

BAKER HUGHES, A GE COMPAN...

1. A method of treating a subterranean formation penetrated by a wellbore, the method comprising:introducing into the subterranean formation a treatment fluid comprising coated polymeric particles having a polymeric core and a curable thermoset coating disposed on the polymeric core, the polymeric core comprising a rubber, the rubber comprising a nitrile rubber (NBR), a hydrogenated nitrile rubber (HNBR), a styrene-butadiene rubber (SBR), an ethylene propylene diene monomer rubber (EPDM), a natural rubber, a silicone rubber, a polybutadiene, polyisoprene, butyl rubber, or a combination comprising at least one of the foregoing, the curable thermoset coating having a thickness of about 10 ?m to about 50 ?m, and the coated polymeric particles having a true specific gravity of about 0.5 g/cc to about 1.5 g/cc;
allowing the curable thermoset coating to cure under downhole conditions;
forming a fluid-permeable pack from the coated polymeric particles;
flowing a formation fluid through the fluid-permeable pack from the subterranean formation into the wellbore; and
reducing or substantially preventing the passage of formation particles from the subterranean formation into the wellbore.
US Pat. No. 10,766,847

METHOD FOR PRODUCING METHYLMETHACRYLATE

1. A process for producing methyl methacrylate, the process comprising:A) producing methacrolein from propanal and formaldehyde and
B) reacting the methacrolein in an oxidative esterification reaction to obtain methyl methacrylate,
wherein
the producing A) and the reacting B) take place in a liquid phase at a pressure of from 2 to 100 bar, and
the reacting B) is carried out in the presence of a heterogeneous noble-metal-comprising catalyst comprising a metal and/or a metal oxide, and
the reaction mixture of the producing A) is passed into a column for steam stripping, and a top phase of the steam stripper, which comprises the methacrolein and water, is then separated with a phase separator into an upper phase and a lower phase, whereby the upper phase comprises the methacrolein.
US Pat. No. 10,766,848

USE OF POLYMERIZATION INHIBITOR COMPOSITIONS

RHODIA OPERATIONS, Paris...

1. A method for inhibiting polymerization of ethylenically unsaturated monomers that comprise at least one heteroatom, comprising manufacturing, purifying, storing, and/or transporting such monomers in the presence of at least two phenol derivatives and at least one ancillary polymerization inhibitor which is different from the two phenol derivatives, wherein the two phenol derivatives are para-methoxyphenol and pyrocatechol and the at least one ancillary polymerization inhibitor comprises hydroquinone and phenothiazine as a mixture.
US Pat. No. 10,771,970

METHOD OF AUTHENTICATING COMMUNICATION OF AN AUTHENTICATION DEVICE AND AT LEAST ONE AUTHENTICATION SERVER USING LOCAL FACTOR

1. A method for authenticating the communication of an authentication device and at least one authentication server using a local factor, wherein a secret information shared between the authentication device and the at least one authentication server is created within an initializing authentication transaction, characterized in that a reference information is derived from the secret information shared between the authentication device and the at least one authentication server, wherein the reference information is derived from the secret information in the same way in the authentication device and in the at least one authentication server; and the authentication device creates a transformed reference information from the reference information by means of a cryptographic transformation, wherein a local factor chosen and entered by the user or obtained from a medium or from the surrounding environment is used as an input in said cryptographic transformation, and where only the transformed reference information is stored in the authentication device and only the reference information is stored in the at least one authentication server,wherein the local factor is a secret information held by the user; and wherein the local factor or any information from which the local factor could be retrieved is not stored in the authentication device nor in the at least one authentication server, and
wherein in each subsequent authentication transaction using the local factor initialized in the initializing authentication transaction, the authentication device obtains the local factor from the user, from a medium or from the surrounding environment, and the reference information is derived in the authentication device from the stored transformed reference information by means of inverse cryptographic transformation using said obtained local factor as an input for said inverse cryptographic transformation, and the thus obtained reference information is transmitted to the at least one authentication server, where it is verified using the reference information stored in the at least one authentication server.
US Pat. No. 10,765,569

SYNTHETIC SURFACTANT-FREE FINISH, SHEET HAVING SYNTHETIC SURFACTANT-FREE FINISH, ARTICLES HAVING SHEET WITH SYNTHETIC SURFACTANT-FREE FINISH, AND RELATED METHODS

ATTENDS HEALTHCARE PRODUC...

1. A hydrophilic, synthetic sheet comprising:a sheet of synthetic material having a first surface;
where the sheet comprises a hydrophilic finish including molecules of a water-soluble protein dispersed on the first surface;
where the finish includes substantially no synthetic surfactants;
where a 0.5-10% aqueous solution of the water-soluble protein has a surface tension of less than 49 milliNewtons per meter (mN/m); and
the water-soluble protein comprises soy protein isolate.
US Pat. No. 10,766,851

METHOD TO CONVERT LIGNIN 4-O-5 DIARYL ETHERS AND THEIR MODEL COMPOUNDS INTO ORGANIC CHEMICALS

1. A method of converting a diaryl ether source containing 4-O-5 linkages and an inorganic amine chemical or ammonia into an organic compound, comprising reacting said diaryl ether source with the inorganic amine chemical or the ammonia in presence of a catalyst and a reducing agent, transforming the 4-O-5 linkages of said diaryl ether source into the organic compounds, wherein the reducing agent is HCO2Na, formic acid, ammonium formate, NaH, H2 or NaBH4.
US Pat. No. 10,766,853

CATALYTIC PROCESS FOR PREPARING N,N-DIMETHYLGLUCAMINE FROM N METHYLGLUCAMINE

CLARIANT INTERNATIONAL LT...

1. A process for preparing N,N-dimethylglucamine comprising the step of reacting an aqueous solution of N-methylglucamine first with an aqueous solution of formaldehyde at 15-40° C. and subsequently, at a pressure of 20-120 bar and a temperature T=30-68° C., with hydrogen under metal catalysis, wherein, after absorption of hydrogen has completed at 20-68° C., a further, after-hydrogenation is added at 70-120 bar and at 70-110° C.
US Pat. No. 10,767,109

METHOD FOR MANUFACTURING CARBONACEOUS LUMINESCENT MATERIAL

NISSAN CHEMICAL INDUSTRIE...

1. A method for manufacturing a carbonaceous luminescent material, comprising the step of mixing together and heating a starting material containing a polycarboxylic acid and an amino group-containing compound, an acid catalyst and a solvent,wherein the acid catalyst is a heterogeneous acid catalyst,
wherein the heterogeneous acid catalyst is a solid acid catalyst selected from cationic ion-exchange resins, cationic ionic-exchange membranes, and polyphosphoric acid, and
wherein the solvent consists of water.
US Pat. No. 10,767,110

SYSTEM AND METHOD FOR MAKING QUANTUM DOTS

KING ABDULLAH UNIVERSITY ...

1. A system for making a quantum dot (QD), comprising:a mixing device for receiving solution A and solution B, wherein the mixing device is configured to mix solution A and solution B to form solution C;
a first coil in fluidic communication with the mixing device, wherein the first coil is configured to form QD seeds from solution C via nucleation and is connected to a first thermocouple configured for a first temperature; and
a second coil positioned in serial communication with the first coil, wherein the second coil is in fluidic communication with the first coil and directly attached to the first coil, wherein the second coil is configured to grow the QDs from the QD seeds and is connected to a second thermocouple configured for a second temperature, wherein the second temperature is lower than the first temperature,
wherein the first coil and the second coil are independent of one another.
US Pat. No. 10,770,183

METHODS OF ASSESSING A RISK OF DEVELOPING NECROTIZING MENINGOENCEPHALITIS

The Translational Genomic...

6. A method for breeding a canine subject to reduce propensity to necrotizing meningoencephalitis (NME) in progeny resulting from the breeding, the method comprising:extracting genomic DNA from a sample from the canine subject;
assaying the genomic DNA for one or more single nucleotide polymorphisms (SNPs), wherein the SNPs comprise BICF2G630168244 corresponding to position 74522353 on canine chromosome 4 and rs8954494 corresponding to position 53338796 on canine chromosome 15;
detecting a T allele at BICF2G630168244 and an A allele at rs8954494 in the genomic DNA from the sample; and
breeding the canine subject with the T allele at BICF2G630168244 and the A allele at rs8954494 in the genomic DNA from the sample.
US Pat. No. 10,765,318

METHOD FOR TREATING AND REVERSING TYPE 2 DIABETES

1. A method of treating Type 2 Diabetes in a subject, comprising the following steps:following a meal plan based on specific allowed foods and specific avoided foods;
exercising at least 30 minutes a day for 5 days a week by walking, running or biking either outdoors or using a treadmill, an elliptical machine or a stationary bike, and
taking a Supplement 1 and a Supplement 2 each day for the first 30 days of treatment,
wherein Supplement 1 comprises 10 mcg of Zinc, 25 mcg of Copper, 10 mcg of Manganese, 695 mg of a blended substance consisting of Licorice Root, Psyllium, Oat Bran, Celery, Sweet Potato, Apple Pectin, Grapefruit Pectin, and 10 mg of Magnesium and
wherein Supplement 2 comprises 30 mcg of Zinc, 45 mcg of Selenium, 75 mcg of Copper, 30 mcg of Manganese, 100 mcg of Chromium, 525 Lipase Activity Units, 150 mg of Garlic, 60 mg of Tumeric Root, 76 mg of a blended substance consisting of Tumeric Root, Garcinia Cambogia, Cinnamon Verum, Raspberry Ketones, Rhodiola Crenulata and Glucomannanase, and
taking a Supplement 3 and a Supplement 4 each day for an interval of between 2 to 6 months after said first 30 days of treatment wherein the length of the interval depends on the severity of the subject's Type 2 Diabetes as determined by a professional providing said treatment,
wherein Supplement 3 comprises 40 mg of Zinc, 50 mcg of Copper, 20 mcg of Manganese, 150 mg of Milk Thistle Extract, 200 mg of Bayberry Root, 200 mg of Dandelion Root and 400 Lipase Activity Units, and
wherein supplement 4 comprises 1250 IU of Vitamin A, 15 mg of Vitamin C, 4100 IU of Vitamin D, 9.75 IU of Vitamin E, 20 mcg of Vitamin K, 120 mcg of Vitamin K2, 380 mcg of Vitamin B1, 500 mcg of Vitamin B2, 5 mg of Vitamin B3, 500 mcg of Vitamin B6, 100 mcg of Vitamin B9, 10 mcg of Vitamin B12, 10 mcg of Vitamin B7, 2.5 mg of Vitamin B5, 125 mg of Calcium, 4.5 mg of Iron, 50 mg of Magnesium, 4.04 mg of Zinc, 50 mcg of Selenium, 650 mcg of Copper, 500 mcg of Manganese, 100 mcg of Chromium, 20 mcg of Molybdenum, 9 mg of Potassium, 500 mg of a Stabilized Fatty Acid Blend consisting of Borage Oil, Flax Seed Oil, and Algae Oil, 415 mg of a whole food media blend consisting of an organic vegetable blend, an organic fruit blend, vitamins and probiotics, 100 mg of Garlic, 100 mg of Jerusalem Artichoke, 50.6 mg of a blend consisting of Cinnamon Verum, Raspberry Ketones, Rhodiola Crenulated and Glucomannanase, 40 mg of Turmeric, 30 mg of CoQ10 Ubiquinol, 5 mg of Black Strap Molasses, 40 mcg of Kelp, 170 Lipase Activity Units and 1.25 Billion CFU of Stabilized Heat Resistant Probiotics consisting of Lactobacillus, Acidophilus, L-Plantarum, Bulgaricus, Streptococcus, Thermophilus and Enterococcus Faecium.
US Pat. No. 10,766,859

CATALYTIC HYDROGENATION OF NITRILES

BAYER CROPSCIENCE AKTIENG...

1. A process for preparing 2-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]ethanamine or corresponding salts thereof,comprising(A1) hydrogenating [3-chloro-5-(trifluoromethyl)pyridin-2-yl]acetonitrile in the presence of Raney cobalt catalyst.
US Pat. No. 10,767,116

METHOD AND COMPOSITION FOR NEUTRALIZING ACIDIC COMPONENTS IN PETROLEUM REFINING UNITS

Dow Global Technologies L...

1. A process for neutralizing acidic components in a distillation overhead system of a refining unit comprising water condensate and petroleum products, the process comprising:adding to the distillation overhead system a neutralizing amount of a neutralizing composition comprising an aqueous solution of choline hydroxide and an hydrogen-bond donor, the hydrogen bond donor being glycerol, the distillation overhead system including an overhead line off of a distillation column and the neutralizing composition being added in the overhead line.
US Pat. No. 10,767,118

SCAVENGER COMPOSITIONS FOR SULFUR SPECIES

Innophos, Inc., Cranbury...

1. A scavenger composition for reducing hydrogen sulfide emissions from asphalt comprising:a carrier in an amount of about 1.0 wt % to about 99.0 wt. %, based on total weight of the composition, and
an active metal in an amount of about 99.0 wt % to about 1.0 wt. %, based on total weight of the composition,
a dispersant in an amount of about 0.01 wt % to about 10.0 wt. %, based on total weight of the composition, and
a suspension aid in an amount of about 0.01 wt % to about 10.0 wt. %, based on total weight of the composition, wherein the suspension add is chosen from polysaccharides, fumed silica, modified bentonite, hectorites, castor oil derivatives, polyamides, polyolefins, and polyacrylates,
wherein the active metal is a metal salt or metal chelate, and wherein the metal is chosen from iron, copper, molybdenum, nickel and zinc.
US Pat. No. 10,765,072

METHOD OF ACCELERATING THE GROWTH AND DEVELOPMENT OF TREES AND SHRUBS VIA ENHANCED ROOT DEVELOPMENT

1. A method of facilitating air root pruning of seedlings, the method comprising:placing seeds on a surface of a growing medium;
germinating the seeds on the surface of the growing medium to obtain seedlings;
subjecting the seedlings to a first air root pruning by growing the seedlings in a first bottomless container of 2½ inches to 5 inches deep; and
after the first air root pruning, subjecting the seedlings to a second air root pruning by growing the seedlings in a second bottomless container of 3 inches to 5½ inches deep.
US Pat. No. 10,767,121

SIMULTANEOUS CRUDE OIL DEHYDRATION, DESALTING, SWEETENING, AND STABILIZATION

SAUDI ARABIAN OIL COMPANY...

1. An integrated gas oil separation plant system, the system comprising:a crude oil inlet feed stream, the crude oil inlet feed stream operable to convey sour and low pressure crude oil for processing in the system;
a low pressure production trap (LPPT), where the LPPT is fluidly coupled to the crude oil inlet feed stream, and where the LPPT comprises an inlet mixing device operable to thoroughly mix an LPPT inlet feed stream, a plurality of insulated electrostatic electrodes, and a weir;
a low pressure degassing tank (LPDT), where the LPDT is fluidly coupled to the LPPT, and where the LPDT comprises an inlet mixing device operable to thoroughly mix an LPDT inlet feed stream, a plurality of insulated electrostatic electrodes, and a weir, and a stripping gas stream inlet fluidly coupled with the LPDT, the stripping gas stream inlet operable to supply steam in addition to or alternative to a low concentration H2S stripping gas to the LPDT;
an inline gas separator, where the inline gas separator is fluidly disposed in between the crude oil inlet feed stream and the LPPT, and is fluidly disposed between the crude oil inlet feed stream and the LPPT;
a first heat exchanger, where the first heat exchanger is fluidly disposed between the inline gas separator and the LPPT and is fluidly coupled to both the inline gas separator and the LPPT, and where the first heat exchanger is operable to heat the LPPT inlet feed stream;
a second heat exchanger, where the second heat exchanger is fluidly disposed between the LPPT and the LPDT and is fluidly coupled to both the LPPT and LPDT, and where the second heat exchanger is operable to heat the LPDT inlet feed stream;
a LPDT recycle water stream, where the LPDT recycle water stream is operable to supply recycle water from the LPDT to the crude oil inlet feed stream to form the LPPT inlet feed stream;
a desalter unit fluidly disposed between the LPDT and a cold stabilizer, where the desalter unit is operable to remove salt water from crude oil;
a third heat exchanger, the third heat exchanger fluidly disposed between the LPDT and the desalter unit, where the third heat exchanger is operable to heat a crude oil output stream from the LPDT; and
a fresh wash water supply stream, where the fresh wash water supply stream is operable to supply fresh water to the output stream of the LPDT to form a desalter inlet feed stream.
US Pat. No. 10,765,075

MAIZE INBRED PH47CA

PIONEER HI-BRED INTERNATI...

1. A seed, plant, plant part, or plant cell of inbred maize variety PH47CA, representative seed of the variety having been deposited under NCMA accession No. 202004021.
US Pat. No. 10,765,076

MAIZE INBRED PH41A3

PIONEER HI-BRED INTERNATI...

1. A seed, plant, plant part, or plant cell of inbred maize variety PH41A3, representative seed of the variety having been deposited under NCMA accession No. 202004036.
US Pat. No. 10,765,077

SOYBEAN CULTIVAR 81142227

M.S. Technologies, L.L.C....

1. A plant of soybean cultivar 81142227, representative seed of said soybean cultivar having been deposited under NCMA Accession No. 201909084.
US Pat. No. 10,767,126

COMBINATION OF FUEL ADDITIVES

TOTAL MARKETING SERVICES,...

1. A fuel composition that comprises at least:a fuel derived from one or more sources selected from the group consisting of mineral, animal, vegetable and synthetic sources,
from 5 to 1000 ppm of a compound (T1) selected from: polyalkylene glycols, C1-C12 alkyl ethers of polyalkylene glycol, and mixtures thereof,
from 5 to 500 ppm of a compound (T2) selected from nonionic emulsifiers,
wherein the (T1):(T2) weight ratio is from 10:1 to 1:10.
US Pat. No. 10,770,711

CAP ASSEMBLY FOR CYLINDRICAL SECONDARY BATTERY COMPRISING CURRENT INTERRUPT DEVICE COATED WITH INSULATING MATERIAL ON OUTER CIRCUMFERENCE SURFACE

LG Chem, Ltd., Seoul (KR...

1. A cap assembly loaded on an open upper end of a metal battery can of a cylindrical secondary battery, the cap assembly comprising:a top cap at an uppermost end of the cap assembly and including a positive electrode terminal having an outward protruding structure;
a safety vent under the top cap and electrically connected to the top cap via a safety vent for discharging gas;
a current interrupt device configured such that a portion of an upper surface of the current interrupt device is connected to the safety vent and a portion of a lower surface of the current interrupt device is connected to an electrode lead of an electrode assembly, the portion of the current interrupt device connected to the safety vent being configured to rupture when high pressure is generated in the battery, whereby the current interrupt device is separated from the safety vent to interrupt a flow of current;
a current interrupt device (CID) gasket coupled to the current interrupt device so as to wrap an outer circumferential part of the current interrupt device excluding portions of the current interrupt device that are connected to electrode tabs and the safety vent to secure an electrical insulation property of the current interrupt device; and,
an insulative coating layer of an electrically insulative material on the outer circumferential part of the current interrupt device, and
wherein the insulative coating layer is continuously formed on an outer circumferential surface of the current interrupt device and on portions of an upper surface and a lower surface of the current interrupt device that are adjacent to the outer circumferential surface of the current interrupt device, and wherein the insulative coating layer is absent at a center of the upper and lower surfaces of the current interrupt.
US Pat. No. 10,765,078

LETTUCE VARIETY 79-885 RZ

RIJK ZWAAN ZAADTEELT EN Z...

1. A seed of lettuce variety 79-885 RZ, a sample of seed of said variety having been deposited under NCIMB Accession No. 42907.
US Pat. No. 10,770,712

POUCH-TYPED BATTERY CELL COMPRISING ELECTRODE LEAD HAVING CURRENT BREAKING FUNCTION

LG Chem, Ltd., Seoul (KR...

1. A battery cell, comprising:an electrode assembly comprising a positive electrode, a negative electrode, and a separator interposed between the positive electrode and the negative electrode; and
a battery case comprising an upper case and a lower case, at least one of the upper case and the lower case being provided with a receiving part, in which the electrode assembly is mounted, wherein:
one end of each of electrode tabs extending from the electrode assembly is coupled to a corresponding end of an electrode lead, and the electrode lead extends from the electrode tabs to protrude outward from the battery case,
the electrode lead is provided with at least one notch part configured to rupture in response to expansion deformation of the battery case when a pressure in the battery cell increases in order to achieve an electrical cutoff of the battery,
the electrode lead is attached to one of the upper case and the lower case by a first insulative film that is interposed between a portion of one surface of the electrode lead and an inner surface of the one of the upper case and the lower case, the first insulative film is closer to the electrode assembly than the notch part,
the electrode lead is attached to the upper case and the lower case by second insulative films that are interposed respectively between portions of opposite surfaces of the electrode lead and the inner surfaces of the upper case and the lower case such that the second insulative films are farther from the electrode assembly than the notch part and such that the second insulative films seal the battery case,
one of the second insulative films is longer than the other of the second insulative films,
the one of the second insulative films that is longer than the other of the second insulative film is on a surface of the electrode lead that is opposite to the surface of the electrode lead on which the first insulative film is attached, and
the notch part is formed on the surface of the electrode lead that is opposite to the surface of the electrode lead on which the first insulative film is attached.
US Pat. No. 10,765,079

WILD ROCKET VARIETY 89-004 RZ

RIJK ZWAAN ZAADTEELT EN Z...

1. A seed of wild rocket variety 89-004 RZ, a sample of seed of said variety having been deposited under NCIMB Accession No. 42802.
US Pat. No. 10,765,080

SOYBEAN VARIETY 5PHKH06

PIONEER HI-BRED INTERNATI...

1. A plant or a seed of soybean variety 5PHKH06, representative seed of the variety having been deposited under ATCC Accession Number PTA-125410.
US Pat. No. 10,765,336

SYSTEM AND METHOD FOR PLANNING A PATIENT-SPECIFIC CARDIAC PROCEDURE

The Johns Hopkins Univers...

1. A non-invasive computer-implemented method of producing a personalized set of cardiac ablation targets to treat ventricular tachycardia in a living patient's heart, comprising:receiving contrast-enhanced three-dimensional MRI or CT data of at least a portion of said living patient's heart;
segmenting said contrast-enhanced three-dimensional MRI or CT data to obtain three-dimensional heart image data;
segmenting said three-dimensional heart image data into at least three different tissue types of said heart based on said contrast-enhanced three-dimensional MRI or CT data, said at least three different tissue types including a normal tissue region, a scar tissue region and a transition zone region, said transition zone region including an infarct border zone tissue region and being characterized as having electrophysiological properties bounded by the properties of the normal and scar tissue regions;
constructing a model of at least a portion of said living patient's heart, said constructing said model comprising:
creating a finite element mesh using the segmented three-dimensional data, to provide a geometrical representation of said patient's heart, the finite element mesh comprising a plurality of volume elements, wherein the volume elements each represent a volume having an edge length in a range of about 300-400 microns;
determining a fiber orientation in each of the volume elements based on calculations executed on a patient-specific geometry of the patient's heart; and
assigning electrophysiological parameters to each of the volume elements taking into account the determined fiber orientations and the type of tissue where the corresponding volume element is located;
simulating, using a computer, at least one of electrophysiological or electromechanical activity of at least a portion of said living patient's heart using said model, said simulating inducing an arrhythmia in said model of said living patient's heart;
producing, using said model, a personalized set of cardiac ablation targets representing locations in the heart critical to sustaining simulated ventricular tachycardia, such that when the targets are ablated, all simulated ventricular tachycardia is eliminated with a minimal ablation lesion size, wherein said producing a personalized set of cardiac ablation targets comprises simulating an initial target ablation, and upon the initial target ablation not eliminating all the simulated ventricular tachycardia re-calculating the personalized set of cardiac ablation targets; and
exporting said personalized set of ablation targets for use during the ablation procedure to treat ventricular tachycardia.
US Pat. No. 10,767,129

ASPHALT-BASED DUST CONTROL FORMULATIONS

Henry Company, LLC, El S...

1. A method for controlling dust on a surface of a bulk material, comprising:(I) preparing a dust control formulation (DCF) comprising a dust reduction additive (DRA) emulsion comprising:
(i) asphalt,
(ii) at least one first defoamer, and
(iii) at least one emulsifier,
wherein said at least one emulsifier is a low-fatty acid emulsifier comprising:
(a) water,
(b) a fatty acid solution,
(c) a base, and
(d) a stabilizer and
(II) applying said dust control formulation to said surface of said bulk material in an amount effective for dust control.
US Pat. No. 10,770,715

HIGH CAPACITY PRIMARY LITHIUM CELLS AND METHODS OF MAKING THEREOF

Tadiran Batteries Ltd., ...

1. A primary electrochemical lithium cell, comprising:an anode comprising metallic lithium therein;
a cathode comprising a current collector and both a liquid SO2 cathode and a solid cathode which comprises a cathode material characterized by having a first electromotive force (EMF) when coupled to a metallic lithium anode, the first EMF is greater than a second EMF of a cell having a metallic lithium anode and a single liquid SO2 cathode;
an electrolyte solution comprising at least one ionizable salt dissolved in at least one organic solvent; and
a separator disposed between the anode and the solid cathode of the cell.
US Pat. No. 10,765,082

SOYBEAN CULTIVAR 83261548

M.S. Technologies, L.L.C....

1. A plant of soybean cultivar 83261548, representative seed of said soybean cultivar having been deposited under NCMA Accession No. 201909092.